Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
FIB.adventitial.baseline: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 4,286 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Physical function | MISCL000041 | 49.20 | Miscellaneous | Stromal / connective | 502 | 3 | 4 | 9 | |
| 2 | Corneal properties | OPHTH000010 | 44.56 | Ophthalmic | Stromal / connective | 279 | 3 | 5 | 10 | |
| 3 | Height | BMORP000009 | 44.38 | Body morphology | Stromal / connective | 3,280 | 3 | 4 | 6 | |
| 4 | DLK1 levels | PROLV000625 | 39.87 | Protein levels | Muscle / cardiac | 29 | 4 | 9 | 25 | |
| 5 | HMCN2 levels | PROLV000977 | 39.65 | Protein levels | Stromal / connective | 14 | 5 | 10 | 18 | |
| 6 | AGRN/HSPG2 ratio | PRORT000048 | 38.72 | Protein ratios | Stromal / connective | 22 | 7 | 7 | 25 | |
| 7 | Spondylolisthesis or spondylolysis | MSKEL000079 | 38.30 | Musculoskeletal | Stromal / connective | 0 | 3 | 5 | 13 | |
| 8 | Waist circumference, adjusted for BMI | BMORP000006 | 36.85 | Body morphology | Stromal / connective | 314 | 3 | 3 | 9 | |
| 9 | Body size, adult | BMORP000003 | 35.88 | Body morphology | Stromal / connective | 300 | 3 | 6 | 8 | |
| 10 | IFIT3 levels | PROLV001017 | 35.68 | Protein levels | Stromal / connective | 0 | 2 | 5 | 12 | |
| 11 | HSPG2/IGFBP6 ratio | PRORT001307 | 35.18 | Protein ratios | Adipose | 15 | 3 | 9 | 18 | |
| 12 | LAMB1 levels | PROLV001179 | 33.86 | Protein levels | Stromal / connective | 44 | 2 | 9 | 22 | |
| 13 | PTH1R levels | PROLV001668 | 33.40 | Protein levels | Stromal / connective | 30 | 2 | 6 | 9 | |
| 14 | CLMP/GFRA1 ratio | PRORT000668 | 32.67 | Protein ratios | Hepatocyte | 49 | 2 | 9 | 18 | |
| 15 | Intraocular pressure | OPHTH000011 | 31.09 | Ophthalmic | Stromal / connective | 184 | 4 | 6 | 10 | |
| 16 | Coronary artery plaque burden | VASCU000056 | 30.18 | Vascular | Vascular | 37 | 3 | 5 | 9 | |
| 17 | PGLS levels | PROLV001545 | 29.33 | Protein levels | Neural / glial | 0 | 5 | 6 | 27 | |
| 18 | CSF volume | NIMAG000018 | 29.08 | Neuroimaging | Stromal / connective | 16 | 2 | 2 | 6 | |
| 19 | COL24A1 levels | PROLV000486 | 28.25 | Protein levels | Stromal / connective | 2 | 5 | 10 | 25 | |
| 20 | Ventricular sphericity | CARDI000014 | 26.98 | Cardiac | Muscle / cardiac | 0 | 3 | 8 | 21 | |
| 21 | Hip circumference, adjusted for BMI | BMORP000005 | 26.88 | Body morphology | Stromal / connective | 326 | 5 | 6 | 10 | |
| 22 | Leukoencephalopathy | NEURO000004 | 26.12 | Neurologic | Stromal / connective | 2 | 2 | 10 | 7 | |
| 23 | Medication, antiglaucoma | OPHTH000014 | 25.53 | Ophthalmic | Stromal / connective | 69 | 2 | 5 | 12 | |
| 24 | Female genital disorder | REPRO000006 | 25.40 | Reproductive | Stromal / connective | 14 | 4 | 9 | 13 | |
| 25 | Arterial stiffness | VASCU000050 | 23.95 | Vascular | Stromal / connective | 3 | 2 | 3 | 12 | |
| 26 | Lean mass | BCOMP000009 | 23.82 | Body composition | Stromal / connective | 897 | 4 | 7 | 8 | |
| 27 | EFEMP1/FSTL3 ratio | PRORT000986 | 23.76 | Protein ratios | Stromal / connective | 14 | 4 | 6 | 20 | |
| 28 | SCARA5/SCARF2 ratio | PRORT001758 | 23.73 | Protein ratios | Vascular | 4 | 1 | 3 | 18 | |
| 29 | PSPN levels | PROLV001661 | 23.30 | Protein levels | Stromal / connective | 26 | 4 | 9 | 11 | |
| 30 | Hand grip strength | MSKEL000030 | 23.26 | Musculoskeletal | Stromal / connective | 131 | 5 | 7 | 13 | |
| 31 | Coronary artery calcification | VASCU000055 | 23.20 | Vascular | Vascular | 56 | 4 | 6 | 11 | |
| 32 | BGLAP levels | PROLV000193 | 23.06 | Protein levels | Stromal / connective | 19 | 3 | 7 | 17 | |
| 33 | CBLN4 levels | PROLV000272 | 22.88 | Protein levels | Adipose | 11 | 2 | 8 | 9 | |
| 34 | SFRP2 levels | PROLV001845 | 22.76 | Protein levels | Neural / glial | 11 | 4 | 8 | 24 | |
| 35 | PFDN5 levels | PROLV001539 | 22.40 | Protein levels | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 36 | ROBO2 levels | PROLV001750 | 22.04 | Protein levels | Adipose | 69 | 5 | 10 | 24 | |
| 37 | Hydrocephalus | NEURO000002 | 22.02 | Neurologic | Stromal / connective | 10 | 2 | 4 | 16 | |
| 38 | FEV1/FVC ratio | RESPI000021 | 21.91 | Respiratory | Stromal / connective | 549 | 3 | 4 | 17 | |
| 39 | RGMA levels | PROLV001728 | 21.85 | Protein levels | Muscle / cardiac | 126 | 1 | 7 | 11 | |
| 40 | Ocular motility and refraction disorder | OPHTH000024 | 21.44 | Ophthalmic | Adipose | 7 | 3 | 5 | 12 | |
| 41 | LAMA4/NID1 ratio | PRORT001419 | 21.36 | Protein ratios | Vascular | 14 | 5 | 12 | 24 | |
| 42 | Kidney volume | NEPHR000022 | 21.01 | Nephrourologic | Stromal / connective | 1 | 3 | 8 | 25 | |
| 43 | Aortic valve disease | CARDI000053 | 20.75 | Cardiac | Vascular | 83 | 5 | 9 | 17 | |
| 44 | ADGRB3 levels | PROLV000040 | 20.70 | Protein levels | Stromal / connective | 34 | 5 | 8 | 25 | |
| 45 | Ocular refraction | OPHTH000033 | 20.66 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 46 | Arthropathy | MSKEL000013 | 20.62 | Musculoskeletal | Stromal / connective | 24 | 4 | 6 | 20 | |
| 47 | White matter lesion volume | NIMAG000027 | 20.18 | Neuroimaging | Stromal / connective | 30 | 4 | 10 | 14 | |
| 48 | TNXB levels | PROLV002085 | 20.04 | Protein levels | Stromal / connective | 56 | 4 | 7 | 22 | |
| 49 | Glaucoma | OPHTH000009 | 19.92 | Ophthalmic | Stromal / connective | 407 | 3 | 7 | 9 | |
| 50 | CLMP/TNFRSF19 ratio | PRORT000671 | 19.81 | Protein ratios | Stromal / connective | 0 | 2 | 3 | 9 | |
| 51 | Operation, hernia | GASTR000040 | 19.50 | Gastrointestinal | Adipose | 21 | 2 | 5 | 9 | |
| 52 | Nerve entrapment syndrome | NEURO000028 | 19.29 | Neurologic | Stromal / connective | 19 | 4 | 7 | 12 | |
| 53 | Corneal disorder | OPHTH000003 | 19.24 | Ophthalmic | Stromal / connective | 11 | 1 | 1 | 14 | |
| 54 | Ventricular mass-to-volume ratio | CARDI000013 | 19.19 | Cardiac | Muscle / cardiac | 40 | 3 | 5 | 17 | |
| 55 | Pregnancy complication, obstructed labour | REPRO000031 | 19.12 | Reproductive | Stromal / connective | 0 | 3 | 6 | 11 | |
| 56 | Forced expiratory volume, FEV | RESPI000019 | 18.94 | Respiratory | Stromal / connective | 370 | 1 | 5 | 13 | |
| 57 | MYCT1 levels | PROLV001357 | 18.69 | Protein levels | B / plasma cell | 0 | 2 | 6 | 23 | |
| 58 | Cardiac angiography | CARDI000047 | 18.65 | Cardiac | Stromal / connective | 14 | 3 | 8 | 17 | |
| 59 | Tympanic membrane perforation | AUDIO000019 | 18.37 | Auditory | Stromal / connective | 5 | 3 | 6 | 8 | |
| 60 | A body shape index, ABSI | BMORP000001 | 18.32 | Body morphology | Stromal / connective | 203 | 3 | 6 | 12 | |
| 61 | Blood pressure, BP, pulse | VASCU000010 | 18.12 | Vascular | Stromal / connective | 1,008 | 5 | 7 | 16 | |
| 62 | Uterine or vaginal bleeding | REPRO000044 | 18.01 | Reproductive | Stromal / connective | 0 | 5 | 8 | 16 | |
| 63 | HAMP levels | PROLV000950 | 17.70 | Protein levels | Vascular | 8 | 5 | 10 | 10 | |
| 64 | SCARA5 levels | PROLV001780 | 17.70 | Protein levels | Stromal / connective | 8 | 2 | 4 | 9 | |
| 65 | CKAP2 levels | PROLV000438 | 17.59 | Protein levels | Neural / glial | 1 | 4 | 7 | 19 | |
| 66 | Precerebral arterial stenosis and occlusion | VASCU000016 | 17.14 | Vascular | Stromal / connective | 91 | 2 | 11 | 22 | |
| 67 | Knee morphology | MSKEL000024 | 16.90 | Musculoskeletal | Stromal / connective | 0 | 4 | 7 | 17 | |
| 68 | COL6A3/COLEC12 ratio | PRORT000695 | 16.89 | Protein ratios | Adipose | 53 | 4 | 9 | 18 | |
| 69 | NTPROBNP levels | PROLV001446 | 16.82 | Protein levels | Muscle / cardiac | 50 | 2 | 7 | 18 | |
| 70 | Fibromuscular dysplasia | VASCU000024 | 16.69 | Vascular | Stromal / connective | 1 | 3 | 6 | 11 | |
| 71 | MIA/NBL1 ratio | PRORT001532 | 16.44 | Protein ratios | Stromal / connective | 22 | 3 | 7 | 17 | |
| 72 | Corneal keratometry | OPHTH000006 | 16.42 | Ophthalmic | Stromal / connective | 298 | 3 | 5 | 8 | |
| 73 | Hernia | GASTR000008 | 16.32 | Gastrointestinal | Stromal / connective | 183 | 2 | 4 | 8 | |
| 74 | EIF4EBP1 levels | PROLV000697 | 16.26 | Protein levels | Muscle / cardiac | 5 | 3 | 9 | 20 | |
| 75 | Joint replacement | MSKEL000049 | 16.17 | Musculoskeletal | Hepatocyte | 7 | 1 | 5 | 6 | |
| 76 | CPXM2 levels | PROLV000512 | 16.17 | Protein levels | Muscle / cardiac | 0 | 2 | 4 | 14 | |
| 77 | Pregnancy complication, haemorrhage | REPRO000030 | 16.14 | Reproductive | Stromal / connective | 13 | 2 | 3 | 14 | |
| 78 | TPM2 levels | PROLV002095 | 15.88 | Protein levels | Hepatocyte | 9 | 3 | 10 | 17 | |
| 79 | Aortic diameter | VASCU000052 | 15.88 | Vascular | Muscle / cardiac | 215 | 5 | 7 | 19 | |
| 80 | CA2/UBAC1 ratio | PRORT000279 | 15.80 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 10 | |
| 81 | Spinal deformity | MSKEL000077 | 15.80 | Musculoskeletal | Stromal / connective | 0 | 2 | 5 | 13 | |
| 82 | FLRT2/GFRA3 ratio | PRORT001161 | 15.75 | Protein ratios | Granulosa cell | 18 | 2 | 10 | 21 | |
| 83 | Trunk mass | BCOMP000019 | 15.72 | Body composition | Stromal / connective | 381 | 4 | 10 | 14 | |
| 84 | Kidney cyst | NEPHR000004 | 15.71 | Nephrourologic | Stromal / connective | 12 | 1 | 6 | 13 | |
| 85 | Brain ventricle volume | NIMAG000016 | 15.69 | Neuroimaging | Stromal / connective | 27 | 1 | 2 | 13 | |
| 86 | Blood pressure, BP, systolic | VASCU000011 | 15.69 | Vascular | Vascular | 1,562 | 4 | 7 | 13 | |
| 87 | Skin sebum | DERMA000036 | 15.51 | Dermatologic | Stromal / connective | 0 | 2 | 6 | 12 | |
| 88 | Rotator cuff injury | MSKEL000067 | 15.44 | Musculoskeletal | Stromal / connective | 0 | 3 | 7 | 17 | |
| 89 | Forced vital capacity, FVC | RESPI000020 | 15.41 | Respiratory | Stromal / connective | 487 | 4 | 6 | 8 | |
| 90 | SVEP1 levels | PROLV001982 | 15.35 | Protein levels | Vascular | 7 | 2 | 7 | 4 | |
| 91 | Waist-hip ratio | BMORP000014 | 15.35 | Body morphology | Adipose | 523 | 3 | 5 | 10 | |
| 92 | ESAM/LAMA4 ratio | PRORT001063 | 15.33 | Protein ratios | Vascular | 16 | 4 | 9 | 15 | |
| 93 | TGFBR2/TNFRSF19 ratio | PRORT001834 | 14.98 | Protein ratios | Neural / glial | 12 | 3 | 7 | 13 | |
| 94 | VCAN levels | PROLV002156 | 14.94 | Protein levels | Adipose | 116 | 3 | 8 | 21 | |
| 95 | EDN1 levels | PROLV000676 | 14.87 | Protein levels | Hepatocyte | 33 | 4 | 11 | 22 | |
| 96 | Bowel function | GASTR000002 | 14.85 | Gastrointestinal | Neural / glial | 18 | 5 | 9 | 11 | |
| 97 | Anaemia of chronic disease | HEMAT000002 | 14.85 | Hematologic | Hepatocyte | 4 | 3 | 6 | 15 | |
| 98 | NHLRC3 levels | PROLV001403 | 14.62 | Protein levels | Stromal / connective | 23 | 5 | 9 | 27 | |
| 99 | CD34 levels | PROLV000336 | 14.59 | Protein levels | Stromal / connective | 67 | 3 | 10 | 21 | |
| 100 | Bone fragility disorder | MSKEL000007 | 14.50 | Musculoskeletal | Adipose | 23 | 5 | 15 | 25 | |
| 101 | Retinal detachments and defects | OPHTH000039 | 14.44 | Ophthalmic | Stromal / connective | 2 | 3 | 7 | 22 | |
| 102 | Frailty, multimorbidity | METBL000012 | 14.44 | Metabolic | Vascular | 188 | 3 | 10 | 10 | |
| 103 | Thigh muscle volume | BMORP000020 | 14.43 | Body morphology | Muscle / cardiac | 16 | 4 | 8 | 17 | |
| 104 | CDON levels | PROLV000385 | 14.36 | Protein levels | Granulosa cell | 4 | 5 | 10 | 14 | |
| 105 | Family history, chronic lung disease | RESPI000002 | 14.36 | Respiratory | Stromal / connective | 0 | 2 | 6 | 14 | |
| 106 | Phosphate | METAB000048 | 14.33 | Metabolites | Hepatocyte | 604 | 1 | 7 | 10 | |
| 107 | FGF2 levels | PROLV000794 | 14.32 | Protein levels | Adipose | 20 | 2 | 4 | 16 | |
| 108 | Body proportion | BMORP000019 | 14.17 | Body morphology | Stromal / connective | 71 | 3 | 8 | 8 | |
| 109 | Aortic elasticity | VASCU000049 | 14.14 | Vascular | Vascular | 20 | 3 | 5 | 12 | |
| 110 | PRELP levels | PROLV001627 | 14.08 | Protein levels | Stromal / connective | 71 | 4 | 9 | 11 | |
| 111 | Medication, beta blocker | VASCU000034 | 14.00 | Vascular | Vascular | 48 | 3 | 8 | 16 | |
| 112 | Medication, laxative | GASTR000016 | 13.91 | Gastrointestinal | Myeloid | 0 | 2 | 4 | 15 | |
| 113 | Peak expiratory flow | RESPI000023 | 13.87 | Respiratory | Stromal / connective | 305 | 2 | 5 | 8 | |
| 114 | FAM174A levels | PROLV000763 | 13.86 | Protein levels | Adipose | 0 | 1 | 9 | 10 | |
| 115 | CD55/PTGDS ratio | PRORT000471 | 13.86 | Protein ratios | Vascular | 1 | 3 | 8 | 21 | |
| 116 | PAEP levels | PROLV001485 | 13.84 | Protein levels | Myeloid | 0 | 2 | 3 | 13 | |
| 117 | EIF4G1/TBC1D23 ratio | PRORT001014 | 13.39 | Protein ratios | Adipose | 1 | 3 | 7 | 13 | |
| 118 | ERBB2 levels | PROLV000724 | 13.31 | Protein levels | Hepatocyte | 97 | 1 | 8 | 17 | |
| 119 | Endometriosis | REPRO000005 | 13.26 | Reproductive | Stromal / connective | 49 | 1 | 4 | 8 | |
| 120 | Chloride | METAB000044 | 13.18 | Metabolites | Hepatocyte | 527 | 0 | 6 | 11 | |
| 121 | PTN levels | PROLV001669 | 13.11 | Protein levels | Hepatocyte | 35 | 5 | 12 | 30 | |
| 122 | FAP levels | PROLV000769 | 12.93 | Protein levels | Adipose | 78 | 7 | 12 | 27 | |
| 123 | CALCA levels | PROLV000255 | 12.87 | Protein levels | Stromal / connective | 6 | 4 | 7 | 22 | |
| 124 | Visual impairment | OPHTH000046 | 12.87 | Ophthalmic | Stromal / connective | 28 | 0 | 2 | 7 | |
| 125 | NPPB levels | PROLV001424 | 12.82 | Protein levels | Muscle / cardiac | 22 | 3 | 8 | 18 | |
| 126 | Bone mineral density | MSKEL000004 | 12.73 | Musculoskeletal | Stromal / connective | 350 | 3 | 8 | 10 | |
| 127 | DLK1/PIK3IP1 ratio | PRORT000912 | 12.72 | Protein ratios | Stromal / connective | 1 | 4 | 10 | 35 | |
| 128 | COL6A3/HSPG2 ratio | PRORT000697 | 12.67 | Protein ratios | Stromal / connective | 49 | 3 | 7 | 15 | |
| 129 | Optic cup area | OPHTH000028 | 12.62 | Ophthalmic | Vascular | 5 | 3 | 9 | 14 | |
| 130 | Refractive errors | OPHTH000034 | 12.56 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 131 | Heart rate | CARDI000021 | 12.47 | Cardiac | Muscle / cardiac | 1,425 | 2 | 8 | 13 | |
| 132 | ANGPTL4 levels | PROLV000098 | 12.43 | Protein levels | Hepatocyte | 49 | 3 | 9 | 23 | |
| 133 | IL4R levels | PROLV001075 | 12.38 | Protein levels | Hepatocyte | 92 | 2 | 11 | 15 | |
| 134 | ZNRF4 levels | PROLV002214 | 12.36 | Protein levels | Adipose | 7 | 5 | 11 | 14 | |
| 135 | Hyperthyroidism, subclinical in pregnancy | ENDOC000011 | 12.36 | Endocrine | Adipose | 1 | 3 | 9 | 14 | |
| 136 | Hip index | BMORP000012 | 12.36 | Body morphology | Adipose | 121 | 3 | 4 | 14 | |
| 137 | COL6A3/NBL1 ratio | PRORT000698 | 12.27 | Protein ratios | Stromal / connective | 29 | 2 | 2 | 8 | |
| 138 | BCAM/EPO ratio | PRORT000208 | 12.18 | Protein ratios | Vascular | 30 | 2 | 8 | 10 | |
| 139 | SRPK2/VASH1 ratio | PRORT001815 | 12.08 | Protein ratios | Muscle / cardiac | 0 | 4 | 12 | 25 | |
| 140 | CAMK1D levels | PROLV000259 | 12.02 | Protein levels | Hepatocyte | 9 | 2 | 8 | 12 | |
| 141 | Coronary revascularization | VASCU000059 | 11.93 | Vascular | Vascular | 384 | 4 | 9 | 25 | |
| 142 | Microscopic colitis | IMMUN000033 | 11.84 | Immunologic | Muscle / cardiac | 7 | 1 | 4 | 12 | |
| 143 | ART3/RGMA ratio | PRORT000145 | 11.79 | Protein ratios | Muscle / cardiac | 17 | 3 | 8 | 15 | |
| 144 | UBAC1 levels | PROLV002132 | 11.76 | Protein levels | Muscle / cardiac | 4 | 2 | 6 | 11 | |
| 145 | Exercise workload | CARDI000024 | 11.61 | Cardiac | Neural / glial | 0 | 5 | 11 | 28 | |
| 146 | BAMBI levels | PROLV000177 | 11.58 | Protein levels | Stromal / connective | 10 | 0 | 1 | 10 | |
| 147 | Cancer, Brain | MALIG000010 | 11.56 | Malignancy | Muscle / cardiac | 0 | 2 | 4 | 13 | |
| 148 | ROBO2/SFTPD ratio | PRORT001746 | 11.43 | Protein ratios | Neural / glial | 15 | 1 | 5 | 19 | |
| 149 | CCN5/IGFBP6 ratio | PRORT000375 | 11.22 | Protein ratios | Stromal / connective | 6 | 1 | 3 | 18 | |
| 150 | AGRN/BTN2A1 ratio | PRORT000046 | 11.21 | Protein ratios | Adipose | 70 | 2 | 7 | 7 | |
| 151 | CKB levels | PROLV000440 | 11.14 | Protein levels | Muscle / cardiac | 40 | 3 | 5 | 15 | |
| 152 | Prolapse, pelvic organ | REPRO000025 | 11.11 | Reproductive | Stromal / connective | 35 | 3 | 6 | 13 | |
| 153 | STX16 levels | PROLV001967 | 11.04 | Protein levels | Muscle / cardiac | 7 | 4 | 5 | 17 | |
| 154 | THOP1 levels | PROLV002028 | 10.99 | Protein levels | Muscle / cardiac | 14 | 5 | 6 | 13 | |
| 155 | GFRA1 levels | PROLV000876 | 10.92 | Protein levels | Myeloid | 22 | 2 | 8 | 15 | |
| 156 | Lens disorder | OPHTH000013 | 10.85 | Ophthalmic | Stromal / connective | 3 | 5 | 8 | 10 | |
| 157 | RET levels | PROLV001724 | 10.81 | Protein levels | Stromal / connective | 18 | 5 | 10 | 21 | |
| 158 | SOD3 levels | PROLV001918 | 10.78 | Protein levels | Myeloid | 84 | 3 | 9 | 10 | |
| 159 | AKT1S1/TDRKH ratio | PRORT000066 | 10.73 | Protein ratios | Stromal / connective | 0 | 3 | 9 | 28 | |
| 160 | Viral intestinal infection | IMMUN000077 | 10.68 | Immunologic | Hepatocyte | 3 | 1 | 5 | 11 | |
| 161 | Blood pressure, BP, diastolic | VASCU000009 | 10.66 | Vascular | Vascular | 1,488 | 3 | 6 | 10 | |
| 162 | CR2 levels | PROLV000514 | 10.65 | Protein levels | B / plasma cell | 95 | 3 | 9 | 11 | |
| 163 | Personal medical history | MISCL000011 | 10.64 | Miscellaneous | Neural / glial | 0 | 0 | 3 | 7 | |
| 164 | ALDH1A1 levels | PROLV000079 | 10.63 | Protein levels | Hepatocyte | 16 | 2 | 9 | 22 | |
| 165 | Osteoporosis | MSKEL000010 | 10.63 | Musculoskeletal | Stromal / connective | 5 | 3 | 5 | 21 | |
| 166 | Bone marrow fat fraction, femur | MSKEL000001 | 10.50 | Musculoskeletal | Adipose | 27 | 3 | 8 | 14 | |
| 167 | GAPDH levels | PROLV000853 | 10.50 | Protein levels | Muscle / cardiac | 0 | 3 | 9 | 33 | |
| 168 | Barrett's oesophagus | GASTR000046 | 10.43 | Gastrointestinal | Stromal / connective | 11 | 2 | 6 | 14 | |
| 169 | CST3/EFEMP1 ratio | PRORT000782 | 10.36 | Protein ratios | Hepatocyte | 26 | 1 | 6 | 15 | |
| 170 | Auditory performance | AUDIO000009 | 10.32 | Auditory | Neural / glial | 0 | 4 | 11 | 26 | |
| 171 | CCL22/PDGFB ratio | PRORT000351 | 10.31 | Protein ratios | Hepatocyte | 7 | 3 | 15 | 43 | |
| 172 | Aortic aneurysm | VASCU000002 | 10.28 | Vascular | Vascular | 163 | 5 | 11 | 20 | |
| 173 | Anterior eye disorder | OPHTH000001 | 10.28 | Ophthalmic | Lymphocyte | 38 | 3 | 15 | 21 | |
| 174 | ARG1 levels | PROLV000134 | 10.25 | Protein levels | Muscle / cardiac | 18 | 3 | 13 | 28 | |
| 175 | Brainstem volume | NIMAG000017 | 10.23 | Neuroimaging | Neural / glial | 10 | 3 | 5 | 15 | |
| 176 | SCARF2 levels | PROLV001783 | 10.18 | Protein levels | Adipose | 49 | 2 | 6 | 11 | |
| 177 | Brain neuroimaging feature | NIMAG000005 | 10.17 | Neuroimaging | Stromal / connective | 137 | 0 | 2 | 9 | |
| 178 | FOXJ3 levels | PROLV000825 | 10.17 | Protein levels | Stromal / connective | 0 | 5 | 9 | 28 | |
| 179 | Body water mass | BCOMP000006 | 10.14 | Body composition | Stromal / connective | 324 | 5 | 10 | 21 | |
| 180 | BOC levels | PROLV000207 | 10.13 | Protein levels | Stromal / connective | 7 | 5 | 15 | 42 | |
| 181 | Anaemia of chronic kidney disease | HEMAT000003 | 10.07 | Hematologic | Hepatocyte | 4 | 3 | 7 | 14 | |
| 182 | IRF3 levels | PROLV001100 | 10.07 | Protein levels | Neural / glial | 0 | 3 | 6 | 12 | |
| 183 | GDNF levels | PROLV000872 | 9.93 | Protein levels | Muscle / cardiac | 3 | 3 | 3 | 13 | |
| 184 | Angina pectoris | CARDI000039 | 9.93 | Cardiac | Vascular | 317 | 5 | 9 | 18 | |
| 185 | Perivascular space burden | NIMAG000011 | 9.91 | Neuroimaging | Muscle / cardiac | 3 | 2 | 5 | 7 | |
| 186 | CLIP2/DNAJA2 ratio | PRORT000665 | 9.82 | Protein ratios | Muscle / cardiac | 0 | 3 | 10 | 18 | |
| 187 | Fat-free mass | BCOMP000008 | 9.61 | Body composition | Stromal / connective | 273 | 6 | 9 | 12 | |
| 188 | CA1 levels | PROLV000239 | 9.60 | Protein levels | Lymphocyte | 0 | 2 | 13 | 28 | |
| 189 | EFEMP1/TGFBR3 ratio | PRORT000988 | 9.56 | Protein ratios | Stromal / connective | 5 | 3 | 7 | 15 | |
| 190 | MSTN/RGMA ratio | PRORT001564 | 9.55 | Protein ratios | Muscle / cardiac | 12 | 2 | 12 | 27 | |
| 191 | Macular puckering of retina | OPHTH000037 | 9.49 | Ophthalmic | Stromal / connective | 17 | 3 | 8 | 11 | |
| 192 | BCAN/NCAN ratio | PRORT000218 | 9.45 | Protein ratios | Granulosa cell | 5 | 5 | 8 | 16 | |
| 193 | HLA-E levels | PROLV000976 | 9.43 | Protein levels | Stromal / connective | 104 | 1 | 7 | 30 | |
| 194 | Sulcal opening distance | NIMAG000012 | 9.43 | Neuroimaging | Vascular | 11 | 5 | 9 | 18 | |
| 195 | Arm mass | BCOMP000014 | 9.41 | Body composition | Stromal / connective | 302 | 4 | 9 | 13 | |
| 196 | DNER levels | PROLV000637 | 9.38 | Protein levels | Vascular | 69 | 1 | 6 | 18 | |
| 197 | SLITRK6 levels | PROLV001890 | 9.32 | Protein levels | Adipose | 4 | 2 | 11 | 17 | |
| 198 | Pelvic morphology | BMORP000021 | 9.31 | Body morphology | Stromal / connective | 54 | 3 | 5 | 6 | |
| 199 | FGF5 levels | PROLV000797 | 9.29 | Protein levels | Hepatocyte | 31 | 3 | 5 | 10 | |
| 200 | Knee extension strength | MSKEL000031 | 9.17 | Musculoskeletal | Stromal / connective | 0 | 2 | 6 | 10 | |
| 201 | MSTN levels | PROLV001345 | 9.12 | Protein levels | Muscle / cardiac | 17 | 2 | 9 | 17 | |
| 202 | LTBR/SIRPB1 ratio | PRORT001466 | 9.12 | Protein ratios | Lymphocyte | 1 | 1 | 3 | 17 | |
| 203 | PPME1 levels | PROLV001612 | 9.07 | Protein levels | Vascular | 9 | 4 | 12 | 31 | |
| 204 | Spinal stenosis | MSKEL000078 | 9.02 | Musculoskeletal | Stromal / connective | 43 | 4 | 9 | 11 | |
| 205 | VEGFA levels | PROLV002157 | 9.00 | Protein levels | Muscle / cardiac | 30 | 1 | 5 | 14 | |
| 206 | Diverticular disease | GASTR000011 | 8.98 | Gastrointestinal | Stromal / connective | 95 | 3 | 6 | 17 | |
| 207 | Atrial volume | CARDI000009 | 8.93 | Cardiac | Stromal / connective | 0 | 3 | 9 | 19 | |
| 208 | Blood pressure, BP, arterial | VASCU000007 | 8.89 | Vascular | Vascular | 603 | 3 | 7 | 9 | |
| 209 | PDGFB/SPARC ratio | PRORT001645 | 8.81 | Protein ratios | Granulosa cell | 9 | 4 | 11 | 31 | |
| 210 | COLEC12/OGN ratio | PRORT000705 | 8.65 | Protein ratios | Stromal / connective | 12 | 3 | 11 | 19 | |
| 211 | PROK2 levels | PROLV001639 | 8.62 | Protein levels | Hepatocyte | 4 | 4 | 9 | 11 | |
| 212 | Osteoarthritis, OA | MSKEL000012 | 8.62 | Musculoskeletal | Stromal / connective | 85 | 1 | 2 | 6 | |
| 213 | SESTD1 levels | PROLV001838 | 8.58 | Protein levels | Muscle / cardiac | 12 | 4 | 8 | 23 | |
| 214 | Operation, vascular | VASCU000058 | 8.58 | Vascular | Vascular | 116 | 4 | 7 | 10 | |
| 215 | C21orf58 levels | PROLV000231 | 8.52 | Protein levels | Hepatocyte | 0 | 4 | 10 | 17 | |
| 216 | Hearing aid use | AUDIO000011 | 8.48 | Auditory | Epithelial | 12 | 1 | 5 | 9 | |
| 217 | DLK1/RGMB ratio | PRORT000913 | 8.45 | Protein ratios | Hepatocyte | 11 | 4 | 9 | 23 | |
| 218 | CHCHD6 levels | PROLV000425 | 8.41 | Protein levels | Stromal / connective | 0 | 3 | 8 | 26 | |
| 219 | EGFR/FAP ratio | PRORT001000 | 8.40 | Protein ratios | Adipose | 52 | 4 | 8 | 17 | |
| 220 | DAG1/SCARF1 ratio | PRORT000853 | 8.40 | Protein ratios | Myeloid | 7 | 3 | 5 | 11 | |
| 221 | Medication, coronary artery disease | VASCU000037 | 8.36 | Vascular | Vascular | 121 | 5 | 8 | 17 | |
| 222 | IL6ST levels | PROLV001079 | 8.25 | Protein levels | Hepatocyte | 62 | 2 | 7 | 15 | |
| 223 | Labour complication | REPRO000037 | 8.22 | Reproductive | Stromal / connective | 0 | 1 | 4 | 7 | |
| 224 | MNDA levels | PROLV001329 | 8.20 | Protein levels | Muscle / cardiac | 1 | 4 | 10 | 20 | |
| 225 | Plant sterols | METAB000074 | 8.19 | Metabolites | Hepatocyte | 6 | 2 | 4 | 14 | |
| 226 | CD99/MMP3 ratio | PRORT000535 | 8.17 | Protein ratios | Hepatocyte | 6 | 1 | 7 | 14 | |
| 227 | Intracerebral haemorrhage | VASCU000014 | 8.16 | Vascular | Stromal / connective | 0 | 6 | 14 | 20 | |
| 228 | CST3/IGFBP6 ratio | PRORT000783 | 8.15 | Protein ratios | Stromal / connective | 7 | 3 | 15 | 19 | |
| 229 | Heel quantitative ultrasound | MSKEL000005 | 8.12 | Musculoskeletal | Stromal / connective | 361 | 3 | 8 | 12 | |
| 230 | CNTN1 levels | PROLV000475 | 8.02 | Protein levels | Stromal / connective | 121 | 4 | 10 | 25 | |
| 231 | Urinary metabolite ratio | METAB000057 | 8.01 | Metabolites | Hepatocyte | 1 | 1 | 4 | 17 | |
| 232 | Benign neoplasm, Melanocytic | MALIG000004 | 7.99 | Malignancy | Stromal / connective | 2 | 0 | 0 | 5 | |
| 233 | PPY levels | PROLV001622 | 7.98 | Protein levels | Vascular | 12 | 0 | 2 | 9 | |
| 234 | Medication, post-myocardial infarction | CARDI000045 | 7.89 | Cardiac | Vascular | 76 | 4 | 9 | 11 | |
| 235 | ST6GALNAC2 levels | PROLV001954 | 7.87 | Protein levels | Neural / glial | 11 | 3 | 8 | 11 | |
| 236 | Glomerular disease | NEPHR000006 | 7.82 | Nephrourologic | Adipose | 5 | 2 | 3 | 9 | |
| 237 | Amino sugar metabolites | METAB000034 | 7.81 | Metabolites | Lymphocyte | 0 | 1 | 5 | 20 | |
| 238 | AZU1/RNASE3 ratio | PRORT000186 | 7.79 | Protein ratios | Myeloid | 1 | 2 | 4 | 11 | |
| 239 | Medication, diuretic | VASCU000038 | 7.78 | Vascular | Vascular | 21 | 1 | 5 | 16 | |
| 240 | Myo-inositol | METAB000036 | 7.75 | Metabolites | Lymphocyte | 0 | 1 | 10 | 27 | |
| 241 | MED18/ZBTB16 ratio | PRORT001512 | 7.75 | Protein ratios | Muscle / cardiac | 10 | 1 | 3 | 13 | |
| 242 | Cardiac implants and grafts | CARDI000048 | 7.74 | Cardiac | Vascular | 36 | 4 | 9 | 23 | |
| 243 | ATG4A levels | PROLV000159 | 7.74 | Protein levels | Vascular | 0 | 3 | 11 | 31 | |
| 244 | COL6A3/CST3 ratio | PRORT000696 | 7.73 | Protein ratios | Adipose | 33 | 3 | 8 | 18 | |
| 245 | Weight, birth | BMORP000018 | 7.72 | Body morphology | Vascular | 117 | 2 | 6 | 16 | |
| 246 | AXIN1/IKBKG ratio | PRORT000171 | 7.68 | Protein ratios | Muscle / cardiac | 10 | 5 | 13 | 29 | |
| 247 | GOLM2/STC1 ratio | PRORT001223 | 7.68 | Protein ratios | Vascular | 15 | 1 | 5 | 9 | |
| 248 | Otitis externa | AUDIO000003 | 7.66 | Auditory | Muscle / cardiac | 0 | 3 | 6 | 17 | |
| 249 | Intervertebral disc disorder | MSKEL000076 | 7.66 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 250 | CNTNAP4 levels | PROLV000481 | 7.64 | Protein levels | Lymphocyte | 38 | 0 | 7 | 16 | |
| 251 | CLEC4D/MANSC1 ratio | PRORT000656 | 7.63 | Protein ratios | Muscle / cardiac | 16 | 3 | 9 | 15 | |
| 252 | Ischaemic heart disease | CARDI000041 | 7.61 | Cardiac | Vascular | 595 | 3 | 10 | 19 | |
| 253 | Trigger finger | MSKEL000072 | 7.60 | Musculoskeletal | Stromal / connective | 7 | 2 | 4 | 8 | |
| 254 | Medication, macular degeneration | OPHTH000015 | 7.59 | Ophthalmic | Hepatocyte | 41 | 3 | 11 | 20 | |
| 255 | CCL17/CCL22 ratio | PRORT000342 | 7.55 | Protein ratios | Muscle / cardiac | 3 | 4 | 10 | 31 | |
| 256 | Retrobulbar neuritis | NEURO000006 | 7.49 | Neurologic | Hepatocyte | — | 1 | 6 | 12 | |
| 257 | CCL11/CCL2 ratio | PRORT000335 | 7.47 | Protein ratios | Muscle / cardiac | 13 | 2 | 5 | 11 | |
| 258 | PRKG1 levels | PROLV001633 | 7.46 | Protein levels | Stromal / connective | 10 | 4 | 7 | 15 | |
| 259 | Macular degeneration | OPHTH000036 | 7.43 | Ophthalmic | Hepatocyte | 106 | 2 | 7 | 15 | |
| 260 | COL6A3/SPON2 ratio | PRORT000701 | 7.43 | Protein ratios | Neural / glial | 20 | 3 | 6 | 25 | |
| 261 | CELA3A/CPB1 ratio | PRORT000594 | 7.36 | Protein ratios | Vascular | 26 | 1 | 3 | 10 | |
| 262 | Neurological disorder | NEURO000008 | 7.33 | Neurologic | Muscle / cardiac | 0 | 1 | 7 | 7 | |
| 263 | Polycystic ovary syndrome | REPRO000024 | 7.32 | Reproductive | Granulosa cell | 29 | 2 | 4 | 19 | |
| 264 | DNAJC9 levels | PROLV000636 | 7.30 | Protein levels | Muscle / cardiac | 1 | 2 | 11 | 35 | |
| 265 | SFTPD levels | PROLV001849 | 7.28 | Protein levels | Vascular | 77 | 1 | 5 | 14 | |
| 266 | TNFRSF1B levels | PROLV002069 | 7.27 | Protein levels | Lymphocyte | 74 | 1 | 7 | 21 | |
| 267 | NTN4 levels | PROLV001445 | 7.23 | Protein levels | Myeloid | 0 | 1 | 4 | 10 | |
| 268 | Consultant specialty, ophthalmology | MISCL000018 | 7.22 | Miscellaneous | Vascular | 0 | 4 | 12 | 22 | |
| 269 | CD79B/FCRL2 ratio | PRORT000511 | 7.19 | Protein ratios | Stromal / connective | 17 | 2 | 7 | 12 | |
| 270 | CLMP/TGFBR2 ratio | PRORT000670 | 7.19 | Protein ratios | Adipose | 11 | 2 | 6 | 6 | |
| 271 | Ankle spacing width | MSKEL000056 | 7.17 | Musculoskeletal | Stromal / connective | 338 | 2 | 5 | 6 | |
| 272 | ADAM9 levels | PROLV000030 | 7.14 | Protein levels | Myeloid | 119 | 3 | 12 | 18 | |
| 273 | Mononeuropathy | NEURO000027 | 7.12 | Neurologic | Stromal / connective | 2 | 0 | 0 | 3 | |
| 274 | ITGAV levels | PROLV001110 | 7.11 | Protein levels | Hepatocyte | 116 | 4 | 14 | 24 | |
| 275 | Myocardial infarction | CARDI000042 | 7.11 | Cardiac | Vascular | 343 | 3 | 9 | 12 | |
| 276 | ROBO2/SCARF2 ratio | PRORT001745 | 7.09 | Protein ratios | Adipose | 12 | 4 | 10 | 12 | |
| 277 | CNST/PRKAR1A ratio | PRORT000684 | 7.05 | Protein ratios | Muscle / cardiac | 7 | 3 | 7 | 17 | |
| 278 | SOST levels | PROLV001922 | 6.93 | Protein levels | Myeloid | 33 | 1 | 5 | 9 | |
| 279 | PRKAR1A/SNAP23 ratio | PRORT001710 | 6.92 | Protein ratios | Hepatocyte | 4 | 3 | 18 | 38 | |
| 280 | Benign neoplasm, Colorectal | MALIG000002 | 6.90 | Malignancy | Stromal / connective | 41 | 0 | 4 | 4 | |
| 281 | DLK1/FAP ratio | PRORT000911 | 6.85 | Protein ratios | Adipose | 26 | 4 | 8 | 25 | |
| 282 | PYY levels | PROLV001690 | 6.84 | Protein levels | Neural / glial | 56 | 2 | 8 | 11 | |
| 283 | AGRN levels | PROLV000057 | 6.83 | Protein levels | Stromal / connective | 53 | 0 | 2 | 8 | |
| 284 | Tyrosine metabolites | METAB000016 | 6.82 | Metabolites | Muscle / cardiac | 0 | 2 | 4 | 16 | |
| 285 | SCT levels | PROLV001795 | 6.81 | Protein levels | Gastrointestinal epithelium | 1 | 0 | 6 | 10 | |
| 286 | Cortical thickness | NIMAG000010 | 6.80 | Neuroimaging | Neural / glial | 39 | 3 | 7 | 20 | |
| 287 | Carpal tunnel surgery | MSKEL000044 | 6.80 | Musculoskeletal | Stromal / connective | 5 | 4 | 6 | 11 | |
| 288 | CXCL17/LAMP3 ratio | PRORT000823 | 6.79 | Protein ratios | Myeloid | 6 | 3 | 15 | 38 | |
| 289 | Emphysema | RESPI000011 | 6.77 | Respiratory | Hepatocyte | 1 | 1 | 7 | 16 | |
| 290 | S100A16 levels | PROLV001770 | 6.76 | Protein levels | Vascular | 10 | 0 | 4 | 9 | |
| 291 | Retinal and choroidal disorder | OPHTH000038 | 6.76 | Ophthalmic | Stromal / connective | 74 | 4 | 9 | 18 | |
| 292 | CLEC3B levels | PROLV000449 | 6.71 | Protein levels | Vascular | 23 | 3 | 7 | 16 | |
| 293 | HSPG2 levels | PROLV000999 | 6.68 | Protein levels | Adipose | 16 | 2 | 5 | 13 | |
| 294 | Infertility | REPRO000010 | 6.68 | Reproductive | Vascular | 0 | 0 | 2 | 9 | |
| 295 | DKK4 levels | PROLV000622 | 6.65 | Protein levels | Vascular | 53 | 2 | 10 | 18 | |
| 296 | CCL16 levels | PROLV000282 | 6.65 | Protein levels | Hepatocyte | 117 | 2 | 8 | 16 | |
| 297 | ROR1 levels | PROLV001751 | 6.64 | Protein levels | Hepatocyte | 77 | 1 | 4 | 10 | |
| 298 | CNTN1/EGFR ratio | PRORT000685 | 6.64 | Protein ratios | Hepatocyte | 69 | 2 | 10 | 12 | |
| 299 | INHBB levels | PROLV001087 | 6.64 | Protein levels | Hepatocyte | 38 | 6 | 10 | 14 | |
| 300 | Peptic ulcer disease | GASTR000051 | 6.63 | Gastrointestinal | Vascular | 12 | 0 | 1 | 5 | |
| 301 | CD74/LILRB4 ratio | PRORT000505 | 6.61 | Protein ratios | Vascular | 42 | 4 | 9 | 21 | |
| 302 | MEPE levels | PROLV001299 | 6.61 | Protein levels | Muscle / cardiac | 39 | 2 | 7 | 17 | |
| 303 | Eye disorder, none | OPHTH000007 | 6.56 | Ophthalmic | Neural / glial | — | 4 | 14 | 11 | |
| 304 | SMPD1 levels | PROLV001901 | 6.54 | Protein levels | Hepatocyte | 179 | 1 | 7 | 16 | |
| 305 | MATN2/SCARA5 ratio | PRORT001494 | 6.54 | Protein ratios | Stromal / connective | 12 | 5 | 9 | 19 | |
| 306 | MPIG6B/PDGFB ratio | PRORT001557 | 6.53 | Protein ratios | Myeloid | 3 | 4 | 11 | 21 | |
| 307 | Cerebellar volume | NIMAG000019 | 6.50 | Neuroimaging | Myeloid | 12 | 0 | 0 | 1 | |
| 308 | Enamel hypoplasia | DENTA000002 | 6.48 | Dental | Vascular | 0 | 0 | 13 | 48 | |
| 309 | Peripheral artery disease | VASCU000042 | 6.48 | Vascular | Vascular | 44 | 3 | 9 | 23 | |
| 310 | IGFBP7 levels | PROLV001033 | 6.46 | Protein levels | Hepatocyte | 24 | 1 | 7 | 17 | |
| 311 | GABARAPL1 levels | PROLV000844 | 6.44 | Protein levels | Hepatocyte | — | 2 | 8 | 14 | |
| 312 | Arrhythmia | CARDI000018 | 6.42 | Cardiac | Muscle / cardiac | 192 | 2 | 4 | 9 | |
| 313 | HSPG2/SMOC2 ratio | PRORT001309 | 6.41 | Protein ratios | Stromal / connective | 32 | 4 | 9 | 16 | |
| 314 | Muscle fat infiltration | BCOMP000011 | 6.40 | Body composition | Myeloid | 40 | 2 | 8 | 20 | |
| 315 | SFTPA2/SFTPD ratio | PRORT001782 | 6.39 | Protein ratios | Epithelial | 11 | 1 | 4 | 4 | |
| 316 | MOG levels | PROLV001332 | 6.37 | Protein levels | Pancreatic epithelium | 7 | 0 | 6 | 13 | |
| 317 | EIF4G1/PLA2G4A ratio | PRORT001013 | 6.36 | Protein ratios | Vascular | 11 | 2 | 10 | 16 | |
| 318 | Eyelid disorder | OPHTH000019 | 6.36 | Ophthalmic | Adipose | 14 | 1 | 1 | 3 | |
| 319 | ITGB1BP2/STAT5B ratio | PRORT001388 | 6.35 | Protein ratios | Muscle / cardiac | 13 | 2 | 7 | 24 | |
| 320 | PKD1 levels | PROLV001564 | 6.35 | Protein levels | Vascular | 84 | 4 | 11 | 19 | |
| 321 | MITD1/SNX9 ratio | PRORT001537 | 6.34 | Protein ratios | Hepatocyte | 2 | 5 | 13 | 26 | |
| 322 | Cerebrovascular disease | VASCU000013 | 6.34 | Vascular | Vascular | 56 | 2 | 6 | 9 | |
| 323 | TNFRSF19 levels | PROLV002067 | 6.30 | Protein levels | Muscle / cardiac | 8 | 1 | 8 | 14 | |
| 324 | C1QL2 levels | PROLV000223 | 6.29 | Protein levels | Vascular | 43 | 2 | 7 | 24 | |
| 325 | LRRN1 levels | PROLV001236 | 6.26 | Protein levels | Muscle / cardiac | 81 | 3 | 8 | 25 | |
| 326 | GPKOW levels | PROLV000925 | 6.24 | Protein levels | Muscle / cardiac | 5 | 4 | 5 | 17 | |
| 327 | COL15A1 levels | PROLV000483 | 6.23 | Protein levels | Stromal / connective | 4 | 0 | 6 | 11 | |
| 328 | MATN2 levels | PROLV001277 | 6.23 | Protein levels | Stromal / connective | 78 | 3 | 6 | 14 | |
| 329 | NAAA/SMPD1 ratio | PRORT001569 | 6.22 | Protein ratios | Granulosa cell | 6 | 3 | 12 | 20 | |
| 330 | Nephritis | NEPHR000024 | 6.22 | Nephrourologic | Hepatocyte | 24 | 0 | 5 | 9 | |
| 331 | SCRN1 levels | PROLV001794 | 6.20 | Protein levels | Adipose | 0 | 3 | 6 | 17 | |
| 332 | Leg mass | BCOMP000017 | 6.17 | Body composition | Neural / glial | 384 | 5 | 10 | 15 | |
| 333 | EDAR levels | PROLV000674 | 6.15 | Protein levels | Hematopoietic progenitor | 11 | 2 | 4 | 9 | |
| 334 | Benign neoplasm, Ocular | MALIG000005 | 6.15 | Malignancy | Melanocyte | 14 | 4 | 8 | 29 | |
| 335 | Valvular heart disease | CARDI000054 | 6.13 | Cardiac | Vascular | 15 | 5 | 9 | 24 | |
| 336 | Benign neoplasm, Uterus | MALIG000008 | 6.12 | Malignancy | Lymphocyte | 38 | 0 | 2 | 26 | |
| 337 | ANGPTL7 levels | PROLV000099 | 6.11 | Protein levels | Stromal / connective | 32 | 2 | 9 | 13 | |
| 338 | CHCHD10 levels | PROLV000424 | 6.11 | Protein levels | Muscle / cardiac | 0 | 4 | 8 | 21 | |
| 339 | SYAP1 levels | PROLV001984 | 6.09 | Protein levels | Platelet | 11 | 3 | 5 | 18 | |
| 340 | Lysophosphatidylcholines | LIPID000054 | 6.07 | Lipids | Neural / glial | 26 | 2 | 4 | 15 | |
| 341 | Weight-to-muscle ratio | BCOMP000010 | 6.06 | Body composition | Neural / glial | 1 | 5 | 8 | 19 | |
| 342 | Basal metabolic rate | METBL000007 | 6.06 | Metabolic | Neural / glial | 298 | 6 | 10 | 20 | |
| 343 | CLMP/PIK3IP1 ratio | PRORT000669 | 6.04 | Protein ratios | Adipose | 1 | 3 | 6 | 10 | |
| 344 | Menstrual disorder | REPRO000021 | 6.03 | Reproductive | Vascular | 6 | 0 | 2 | 3 | |
| 345 | PDP1 levels | PROLV001530 | 5.98 | Protein levels | Hepatocyte | 0 | 0 | 2 | 6 | |
| 346 | AOC3/ITGB1 ratio | PRORT000113 | 5.94 | Protein ratios | Stromal / connective | 16 | 3 | 14 | 10 | |
| 347 | Peripheral vascular disease | VASCU000043 | 5.93 | Vascular | Stromal / connective | 65 | 3 | 6 | 14 | |
| 348 | FABP2 levels | PROLV000752 | 5.93 | Protein levels | Myeloid | 44 | 4 | 10 | 17 | |
| 349 | Aneurysm | VASCU000001 | 5.93 | Vascular | Hepatocyte | 141 | 4 | 8 | 22 | |
| 350 | FLT1 levels | PROLV000815 | 5.91 | Protein levels | Vascular | 40 | 3 | 8 | 15 | |
| 351 | DKK1/VEGFC ratio | PRORT000905 | 5.89 | Protein ratios | Muscle / cardiac | 10 | 1 | 7 | 12 | |
| 352 | Creatine metabolites | METAB000058 | 5.89 | Metabolites | Muscle / cardiac | 0 | 2 | 7 | 10 | |
| 353 | Gynaecomastia | BREAS000003 | 5.87 | Breast | Granulosa cell | 0 | 1 | 4 | 11 | |
| 354 | CA2/PSMG3 ratio | PRORT000277 | 5.86 | Protein ratios | Lymphocyte | 3 | 3 | 4 | 19 | |
| 355 | CNST/ITGB1BP2 ratio | PRORT000683 | 5.84 | Protein ratios | Muscle / cardiac | 8 | 3 | 11 | 19 | |
| 356 | APRT/NSFL1C ratio | PRORT000136 | 5.82 | Protein ratios | Lymphocyte | 0 | 2 | 9 | 25 | |
| 357 | AMBN levels | PROLV000084 | 5.81 | Protein levels | Myeloid | 0 | 1 | 5 | 9 | |
| 358 | Pain, joint | MSKEL000036 | 5.81 | Musculoskeletal | Neural / glial | 6 | 2 | 6 | 24 | |
| 359 | Fatty acids, stearic acid | LIPID000028 | 5.80 | Lipids | Hepatocyte | 0 | 2 | 5 | 9 | |
| 360 | IL6ST/LIFR ratio | PRORT001354 | 5.78 | Protein ratios | Neural / glial | 29 | 1 | 6 | 16 | |
| 361 | Hip joint morphology | MSKEL000023 | 5.76 | Musculoskeletal | Stromal / connective | 56 | 2 | 4 | 7 | |
| 362 | Fasciectomy | MSKEL000045 | 5.74 | Musculoskeletal | Stromal / connective | 11 | 3 | 8 | 14 | |
| 363 | POLR2F levels | PROLV001598 | 5.74 | Protein levels | Muscle / cardiac | 1 | 4 | 8 | 22 | |
| 364 | TNFRSF4/TNFRSF9 ratio | PRORT001854 | 5.72 | Protein ratios | Stromal / connective | 5 | 2 | 8 | 18 | |
| 365 | Fatty acids, undecenoic acid | LIPID000030 | 5.71 | Lipids | Stromal / connective | 0 | 3 | 8 | 17 | |
| 366 | SFRP4 levels | PROLV001846 | 5.70 | Protein levels | Stromal / connective | 10 | 3 | 7 | 9 | |
| 367 | TBC1D23 levels | PROLV001996 | 5.70 | Protein levels | Muscle / cardiac | 15 | 2 | 8 | 18 | |
| 368 | ADAMTSL2 levels | PROLV000036 | 5.70 | Protein levels | Hepatocyte | 72 | 3 | 14 | 23 | |
| 369 | CEP85/ZBTB16 ratio | PRORT000604 | 5.69 | Protein ratios | Muscle / cardiac | 20 | 3 | 12 | 18 | |
| 370 | AIFM1/EGF ratio | PRORT000059 | 5.68 | Protein ratios | Hepatocyte | 15 | 2 | 10 | 20 | |
| 371 | MRAP levels | PROLV001337 | 5.68 | Protein levels | Neural / glial | 0 | 4 | 5 | 19 | |
| 372 | ITGBL1 levels | PROLV001117 | 5.67 | Protein levels | Vascular | 82 | 3 | 11 | 14 | |
| 373 | Coronary artery disease, CAD | VASCU000020 | 5.66 | Vascular | Vascular | 661 | 3 | 10 | 23 | |
| 374 | Digital deformity | MSKEL000053 | 5.65 | Musculoskeletal | Stromal / connective | 0 | 5 | 8 | 33 | |
| 375 | CD38/RELT ratio | PRORT000440 | 5.64 | Protein ratios | Muscle / cardiac | 2 | 2 | 9 | 17 | |
| 376 | EPO levels | PROLV000721 | 5.64 | Protein levels | Muscle / cardiac | 23 | 2 | 7 | 18 | |
| 377 | External ear disorder | AUDIO000001 | 5.63 | Auditory | Hepatocyte | 0 | 2 | 8 | 19 | |
| 378 | LPL levels | PROLV001222 | 5.63 | Protein levels | Hepatocyte | 51 | 2 | 6 | 10 | |
| 379 | Orofacial cleft | DENTA000001 | 5.62 | Dental | Neural / glial | 0 | 1 | 10 | 17 | |
| 380 | SORCS2 levels | PROLV001919 | 5.59 | Protein levels | Neural / glial | 6 | 1 | 7 | 5 | |
| 381 | FST/FSTL3 ratio | PRORT001180 | 5.55 | Protein ratios | Stromal / connective | 0 | 4 | 15 | 20 | |
| 382 | PODXL2/SCG3 ratio | PRORT001695 | 5.55 | Protein ratios | Hepatocyte | 28 | 1 | 7 | 13 | |
| 383 | SMOC2 levels | PROLV001900 | 5.54 | Protein levels | Stromal / connective | 4 | 0 | 1 | 2 | |
| 384 | Musculoskeletal soft tissue disorder | MSKEL000029 | 5.50 | Musculoskeletal | Stromal / connective | 30 | 4 | 7 | 17 | |
| 385 | GSTT2 levels | PROLV000942 | 5.48 | Protein levels | Gastrointestinal epithelium | 0 | 0 | 7 | 8 | |
| 386 | Gestational age at birth | REPRO000040 | 5.47 | Reproductive | Neural / glial | 0 | 1 | 7 | 10 | |
| 387 | Retinal vascular morphology | OPHTH000045 | 5.46 | Ophthalmic | Vascular | 253 | 2 | 5 | 7 | |
| 388 | Haemorrhoidal disease | VASCU000062 | 5.45 | Vascular | Vascular | 67 | 4 | 9 | 16 | |
| 389 | LAP3 levels | PROLV001183 | 5.44 | Protein levels | Vascular | 8 | 2 | 6 | 12 | |
| 390 | HSPA1A/MGLL ratio | PRORT001303 | 5.44 | Protein ratios | Myeloid | 42 | 4 | 10 | 23 | |
| 391 | DKKL1 levels | PROLV000623 | 5.40 | Protein levels | Hepatocyte | 77 | 4 | 10 | 25 | |
| 392 | COL18A1 levels | PROLV000484 | 5.39 | Protein levels | Stromal / connective | 55 | 3 | 7 | 12 | |
| 393 | RGMA/RGMB ratio | PRORT001736 | 5.37 | Protein ratios | Muscle / cardiac | 14 | 1 | 5 | 12 | |
| 394 | CD93/TNFRSF4 ratio | PRORT000532 | 5.36 | Protein ratios | Myeloid | 8 | 2 | 10 | 17 | |
| 395 | ADAMTS8/FAP ratio | PRORT000026 | 5.35 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 7 | |
| 396 | Biventricular shape | CARDI000010 | 5.34 | Cardiac | Muscle / cardiac | 44 | 2 | 4 | 12 | |
| 397 | GET3 levels | PROLV000873 | 5.32 | Protein levels | B / plasma cell | 3 | 2 | 3 | 21 | |
| 398 | LTBP2 levels | PROLV001242 | 5.30 | Protein levels | Myeloid | 145 | 4 | 14 | 23 | |
| 399 | SOD1 levels | PROLV001916 | 5.30 | Protein levels | Lymphocyte | 1 | 2 | 10 | 33 | |
| 400 | PSIP1 levels | PROLV001657 | 5.28 | Protein levels | Muscle / cardiac | 10 | 2 | 10 | 35 | |
| 401 | Retinal disorder | OPHTH000040 | 5.27 | Ophthalmic | Hepatocyte | 88 | 0 | 2 | 3 | |
| 402 | NXPH3 levels | PROLV001458 | 5.27 | Protein levels | Stromal / connective | 3 | 1 | 4 | 15 | |
| 403 | C7 levels | PROLV000236 | 5.25 | Protein levels | Adipose | 12 | 2 | 11 | 27 | |
| 404 | RBP2 levels | PROLV001711 | 5.24 | Protein levels | Neural / glial | 30 | 1 | 10 | 15 | |
| 405 | SFRP1 levels | PROLV001844 | 5.21 | Protein levels | Vascular | 20 | 3 | 6 | 17 | |
| 406 | PRSS53 levels | PROLV001647 | 5.18 | Protein levels | Hepatocyte | 56 | 2 | 9 | 25 | |
| 407 | NID1/NID2 ratio | PRORT001588 | 5.18 | Protein ratios | Lymphocyte | 3 | 3 | 8 | 25 | |
| 408 | Cortical volume | NIMAG000022 | 5.17 | Neuroimaging | Stromal / connective | 22 | 0 | 0 | 0 | |
| 409 | CD55/ITGB1 ratio | PRORT000470 | 5.13 | Protein ratios | Vascular | 51 | 2 | 8 | 22 | |
| 410 | Respiratory insufficiency | RESPI000031 | 5.13 | Respiratory | Hepatocyte | 0 | 4 | 10 | 29 | |
| 411 | FCRL2/KLB ratio | PRORT001129 | 5.13 | Protein ratios | Hepatocyte | 35 | 1 | 5 | 11 | |
| 412 | APRT/MIF ratio | PRORT000135 | 5.13 | Protein ratios | Lymphocyte | 2 | 4 | 14 | 40 | |
| 413 | CCN3/FAP ratio | PRORT000373 | 5.11 | Protein ratios | Hepatocyte | 27 | 4 | 11 | 24 | |
| 414 | XG levels | PROLV002197 | 5.08 | Protein levels | Vascular | 20 | 1 | 4 | 13 | |
| 415 | Cardiovascular disease, none | CARDI000034 | 5.07 | Cardiac | Vascular | 201 | 2 | 5 | 9 | |
| 416 | TGFBR3 levels | PROLV002023 | 5.07 | Protein levels | Adipose | 33 | 3 | 6 | 14 | |
| 417 | JAM2/TGFBR2 ratio | PRORT001397 | 5.05 | Protein ratios | Adipose | 13 | 0 | 4 | 8 | |
| 418 | IL17D levels | PROLV001052 | 5.05 | Protein levels | Hepatocyte | 18 | 4 | 8 | 25 | |
| 419 | FOLH1 levels | PROLV000821 | 5.05 | Protein levels | Hepatocyte | 7 | 0 | 3 | 10 | |
| 420 | PON1 levels | PROLV001600 | 5.04 | Protein levels | Granulosa cell | 40 | 5 | 14 | 21 | |
| 421 | Sex-differentiated cardiometabolic traits | MISCL000002 | 5.04 | Miscellaneous | Hepatocyte | 733 | 1 | 9 | 15 | |
| 422 | Family medical history, none | MISCL000010 | 5.03 | Miscellaneous | Vascular | 6 | 0 | 0 | 3 | |
| 423 | ADAMTS8 levels | PROLV000035 | 5.03 | Protein levels | Muscle / cardiac | 48 | 3 | 5 | 11 | |
| 424 | SPP1 levels | PROLV001938 | 5.03 | Protein levels | Vascular | 68 | 4 | 9 | 23 | |
| 425 | MTSS1 levels | PROLV001349 | 5.03 | Protein levels | Vascular | 14 | 4 | 6 | 7 | |
| 426 | FKBPL levels | PROLV000812 | 5.02 | Protein levels | Vascular | 10 | 1 | 6 | 12 | |
| 427 | KDR/VWF ratio | PRORT001402 | 5.02 | Protein ratios | Vascular | 8 | 2 | 7 | 14 | |
| 428 | Heart failure, with coronary heart disease | CARDI000005 | 5.00 | Cardiac | Stromal / connective | 54 | 3 | 9 | 17 | |
| 429 | PI16 levels | PROLV001553 | 4.99 | Protein levels | Myeloid | 144 | 1 | 6 | 16 | |
| 430 | FAM3B levels | PROLV000766 | 4.99 | Protein levels | Gastrointestinal epithelium | 66 | 0 | 6 | 7 | |
| 431 | CALB1 levels | PROLV000253 | 4.99 | Protein levels | Hepatocyte | 6 | 1 | 10 | 15 | |
| 432 | Heart disease | CARDI000036 | 4.97 | Cardiac | Muscle / cardiac | 66 | 4 | 8 | 25 | |
| 433 | Ventricular wall thickness | CARDI000016 | 4.96 | Cardiac | Muscle / cardiac | 47 | 2 | 3 | 11 | |
| 434 | ECG morphology, unadjusted | ECGRM000002 | 4.95 | Electrocardiogram | Muscle / cardiac | 478 | 2 | 4 | 6 | |
| 435 | ASAH1 levels | PROLV000149 | 4.92 | Protein levels | Myeloid | 48 | 6 | 13 | 26 | |
| 436 | SORD levels | PROLV001920 | 4.89 | Protein levels | Hepatocyte | 44 | 1 | 4 | 11 | |
| 437 | Duodenal ulcer | GASTR000047 | 4.88 | Gastrointestinal | Vascular | 27 | 0 | 4 | 4 | |
| 438 | ECG morphology, adjusted | ECGRM000001 | 4.88 | Electrocardiogram | Muscle / cardiac | 426 | 2 | 3 | 9 | |
| 439 | AGR3 levels | PROLV000056 | 4.85 | Protein levels | Myeloid | 11 | 1 | 7 | 10 | |
| 440 | MYOC/RGMB ratio | PRORT001567 | 4.85 | Protein ratios | Vascular | 11 | 2 | 8 | 15 | |
| 441 | PDCD1LG2 levels | PROLV001516 | 4.85 | Protein levels | Hepatocyte | 48 | 1 | 7 | 10 | |
| 442 | Upper respiratory inflammation | RESPI000041 | 4.85 | Respiratory | Muscle / cardiac | 1 | 1 | 1 | 9 | |
| 443 | SRPX levels | PROLV001945 | 4.85 | Protein levels | Adipose | 32 | 4 | 10 | 16 | |
| 444 | Erectile dysfunction | VASCU000048 | 4.84 | Vascular | Neural / glial | 0 | 4 | 5 | 15 | |
| 445 | ADAMTSL4 levels | PROLV000037 | 4.84 | Protein levels | Myeloid | 49 | 3 | 12 | 24 | |
| 446 | Brain structural connectivity | NIMAG000007 | 4.83 | Neuroimaging | Neural / glial | 35 | 0 | 0 | 0 | |
| 447 | ECG QRS-T angle | CARDI000033 | 4.82 | Cardiac | Muscle / cardiac | 57 | 2 | 4 | 10 | |
| 448 | Chronic viral hepatitis | IMMUN000056 | 4.80 | Immunologic | Stromal / connective | 4 | 0 | 1 | 7 | |
| 449 | Leg fat percentage | BCOMP000015 | 4.78 | Body composition | Neural / glial | 295 | 4 | 7 | 17 | |
| 450 | DDR1/SFTPD ratio | PRORT000880 | 4.78 | Protein ratios | Epithelial | 18 | 1 | 5 | 6 | |
| 451 | BCR/VASH1 ratio | PRORT000230 | 4.77 | Protein ratios | Hepatocyte | 1 | 1 | 6 | 13 | |
| 452 | RNASE4 levels | PROLV001739 | 4.76 | Protein levels | Hepatocyte | 43 | 2 | 7 | 16 | |
| 453 | DPP10 levels | PROLV000645 | 4.75 | Protein levels | Vascular | 10 | 2 | 9 | 19 | |
| 454 | COLEC12/TGFBR2 ratio | PRORT000707 | 4.74 | Protein ratios | Hepatocyte | 75 | 3 | 8 | 18 | |
| 455 | TSTA3 levels | PROLV002118 | 4.74 | Protein levels | Vascular | 10 | 3 | 7 | 12 | |
| 456 | PGF levels | PROLV001544 | 4.73 | Protein levels | Vascular | 24 | 1 | 4 | 14 | |
| 457 | CD177 levels | PROLV000314 | 4.73 | Protein levels | Myeloid | 21 | 1 | 6 | 7 | |
| 458 | PNLIPRP1 levels | PROLV001592 | 4.69 | Protein levels | Gastrointestinal epithelium | 89 | 1 | 4 | 7 | |
| 459 | EGF/TNFSF14 ratio | PRORT000999 | 4.69 | Protein ratios | Hepatocyte | 12 | 4 | 17 | 36 | |
| 460 | Choroid plexus volume | NIMAG000020 | 4.68 | Neuroimaging | Neural / glial | 0 | 0 | 1 | 3 | |
| 461 | DOK2/PDLIM7 ratio | PRORT000940 | 4.68 | Protein ratios | Muscle / cardiac | 6 | 4 | 14 | 19 | |
| 462 | BPIFB1/GLRX ratio | PRORT000245 | 4.64 | Protein ratios | Adipose | 0 | 4 | 9 | 18 | |
| 463 | RPN1 levels | PROLV001754 | 4.64 | Protein levels | Hepatocyte | 2 | 3 | 8 | 15 | |
| 464 | KRT8 levels | PROLV001168 | 4.62 | Protein levels | Adipose | 0 | 0 | 3 | 3 | |
| 465 | Weight change | BMORP000016 | 4.60 | Body morphology | Neural / glial | 0 | 1 | 7 | 21 | |
| 466 | EFEMP1 levels | PROLV000679 | 4.57 | Protein levels | Hepatocyte | 115 | 1 | 5 | 11 | |
| 467 | SPON1 levels | PROLV001936 | 4.53 | Protein levels | Vascular | 33 | 0 | 2 | 7 | |
| 468 | RSPO1/RSPO3 ratio | PRORT001750 | 4.53 | Protein ratios | Myeloid | 5 | 4 | 6 | 14 | |
| 469 | ADAMTSL5 levels | PROLV000038 | 4.51 | Protein levels | Muscle / cardiac | 9 | 4 | 6 | 14 | |
| 470 | TDRKH levels | PROLV002008 | 4.50 | Protein levels | Vascular | 14 | 4 | 6 | 16 | |
| 471 | Phosphatidylethanolamines | LIPID000059 | 4.49 | Lipids | Hepatocyte | 24 | 0 | 1 | 3 | |
| 472 | Nucleoside metabolites | METAB000061 | 4.48 | Metabolites | Vascular | 0 | 0 | 1 | 2 | |
| 473 | TMSB10/ZBTB16 ratio | PRORT001842 | 4.48 | Protein ratios | Muscle / cardiac | 29 | 4 | 8 | 25 | |
| 474 | LTBR levels | PROLV001244 | 4.45 | Protein levels | Hepatocyte | 115 | 1 | 6 | 17 | |
| 475 | PLAUR levels | PROLV001573 | 4.45 | Protein levels | Muscle / cardiac | 4 | 3 | 7 | 25 | |
| 476 | PTPRF/PTPRS ratio | PRORT001721 | 4.44 | Protein ratios | Hepatocyte | 76 | 4 | 11 | 24 | |
| 477 | Menopausal disorder | REPRO000020 | 4.42 | Reproductive | Hepatocyte | 0 | 5 | 9 | 25 | |
| 478 | CDON/SCARA5 ratio | PRORT000581 | 4.42 | Protein ratios | Adipose | 51 | 3 | 7 | 11 | |
| 479 | NT5C3A/PRDX5 ratio | PRORT001602 | 4.39 | Protein ratios | Myeloid | 0 | 2 | 8 | 14 | |
| 480 | Childhood maltreatment | PSYCH000052 | 4.38 | Psychiatric | Vascular | 0 | 1 | 4 | 7 | |
| 481 | NEO1 levels | PROLV001392 | 4.37 | Protein levels | Muscle / cardiac | 0 | 3 | 11 | 19 | |
| 482 | TNFRSF1A levels | PROLV002068 | 4.37 | Protein levels | Stromal / connective | 42 | 0 | 7 | 7 | |
| 483 | Fracture | MSKEL000011 | 4.32 | Musculoskeletal | Stromal / connective | 27 | 1 | 1 | 1 | |
| 484 | Heart failure, chronic | CARDI000003 | 4.31 | Cardiac | Muscle / cardiac | 0 | 3 | 7 | 16 | |
| 485 | EPS8L2 levels | PROLV000723 | 4.31 | Protein levels | Stromal / connective | 20 | 0 | 10 | 20 | |
| 486 | Hydrocele | REPRO000012 | 4.30 | Reproductive | Stromal / connective | 7 | 0 | 8 | 15 | |
| 487 | MIA levels | PROLV001311 | 4.30 | Protein levels | Neural / glial | 91 | 4 | 7 | 14 | |
| 488 | Vitreous disorder | OPHTH000047 | 4.29 | Ophthalmic | Neural / glial | 1 | 2 | 6 | 7 | |
| 489 | CLIP2/NT5C3A ratio | PRORT000667 | 4.29 | Protein ratios | Muscle / cardiac | 0 | 4 | 5 | 13 | |
| 490 | Malocclusion | DENTA000008 | 4.28 | Dental | Stromal / connective | 0 | 0 | 1 | 2 | |
| 491 | JAM2 levels | PROLV001124 | 4.27 | Protein levels | Vascular | 4 | 0 | 5 | 7 | |
| 492 | MAVS/RNF41 ratio | PRORT001499 | 4.27 | Protein ratios | Muscle / cardiac | 19 | 5 | 9 | 16 | |
| 493 | XPNPEP2 levels | PROLV002199 | 4.22 | Protein levels | Hepatocyte | 67 | 2 | 9 | 14 | |
| 494 | FAM3C levels | PROLV000767 | 4.21 | Protein levels | Hepatocyte | 14 | 1 | 4 | 14 | |
| 495 | NCAM2 levels | PROLV001378 | 4.20 | Protein levels | Myeloid | 33 | 3 | 7 | 17 | |
| 496 | TINAGL1 levels | PROLV002041 | 4.20 | Protein levels | Vascular | 55 | 4 | 8 | 15 | |
| 497 | TSPAN8 levels | PROLV002116 | 4.16 | Protein levels | Hepatocyte | 56 | 1 | 9 | 15 | |
| 498 | MXRA8 levels | PROLV001355 | 4.14 | Protein levels | Myeloid | 78 | 5 | 12 | 24 | |
| 499 | SNAP23/ZBTB16 ratio | PRORT001796 | 4.13 | Protein ratios | Lymphocyte | 9 | 3 | 8 | 23 | |
| 500 | FAP/THBS4 ratio | PRORT001117 | 4.12 | Protein ratios | Hepatocyte | 21 | 4 | 12 | 33 | |
| 501 | MSMB levels | PROLV001341 | 4.12 | Protein levels | Stromal / connective | 32 | 3 | 9 | 14 | |
| 502 | Arm impedance | BCOMP000013 | 4.11 | Body composition | Stromal / connective | 665 | 4 | 6 | 12 | |
| 503 | EFEMP1/IL18BP ratio | PRORT000987 | 4.11 | Protein ratios | Stromal / connective | 1 | 1 | 6 | 16 | |
| 504 | FCRL2/SEMA7A ratio | PRORT001131 | 4.11 | Protein ratios | B / plasma cell | 15 | 1 | 8 | 26 | |
| 505 | Gastro-oesophageal reflux disease, GERD | GASTR000045 | 4.10 | Gastrointestinal | Neural / glial | 38 | 2 | 8 | 15 | |
| 506 | GFRA3/LAYN ratio | PRORT001211 | 4.08 | Protein ratios | Adipose | 4 | 3 | 4 | 12 | |
| 507 | SUSD2 levels | PROLV001979 | 4.06 | Protein levels | B / plasma cell | 15 | 3 | 8 | 14 | |
| 508 | COL6A3 levels | PROLV000492 | 4.05 | Protein levels | Stromal / connective | 38 | 2 | 4 | 12 | |
| 509 | CCN2/DKK1 ratio | PRORT000362 | 4.03 | Protein ratios | Muscle / cardiac | 7 | 4 | 13 | 29 | |
| 510 | PCDH7 levels | PROLV001507 | 4.01 | Protein levels | Neural / glial | 6 | 2 | 9 | 16 | |
| 511 | COL1A1/OMD ratio | PRORT000693 | 4.01 | Protein ratios | Hepatocyte | 54 | 4 | 10 | 16 | |
| 512 | Osteopenia | MSKEL000009 | 4.01 | Musculoskeletal | Adipose | 0 | 2 | 10 | 35 | |
| 513 | ARHGEF10 levels | PROLV000140 | 4.01 | Protein levels | Stromal / connective | 25 | 7 | 14 | 21 | |
| 514 | Gut microbial abundance, Rikenellaceae | GASTR000034 | 4.00 | Gastrointestinal | Neural / glial | 0 | 6 | 10 | 28 | |
| 515 | Adhesive capsulitis | MSKEL000058 | 4.00 | Musculoskeletal | Stromal / connective | 26 | 1 | 5 | 13 | |
| 516 | BCL2 levels | PROLV000185 | 3.98 | Protein levels | Lymphocyte | 0 | 5 | 18 | 27 | |
| 517 | RBPMS2 levels | PROLV001714 | 3.97 | Protein levels | Vascular | 13 | 5 | 8 | 19 | |
| 518 | Cortical surface area | NIMAG000009 | 3.96 | Neuroimaging | Neural / glial | 78 | 0 | 0 | 0 | |
| 519 | Optic disc area | OPHTH000029 | 3.95 | Ophthalmic | Vascular | 11 | 4 | 7 | 13 | |
| 520 | DBH levels | PROLV000596 | 3.95 | Protein levels | Myeloid | 48 | 2 | 8 | 16 | |
| 521 | CEBPB levels | PROLV000395 | 3.95 | Protein levels | Hepatocyte | 20 | 2 | 7 | 16 | |
| 522 | MCEE levels | PROLV001284 | 3.94 | Protein levels | Myeloid | 2 | 3 | 11 | 27 | |
| 523 | CHAC2 levels | PROLV000422 | 3.93 | Protein levels | Vascular | 4 | 3 | 10 | 21 | |
| 524 | CCL11/CCL13 ratio | PRORT000334 | 3.92 | Protein ratios | Myeloid | 9 | 2 | 4 | 10 | |
| 525 | ESAM/TGFB1 ratio | PRORT001067 | 3.92 | Protein ratios | Muscle / cardiac | 20 | 4 | 11 | 17 | |
| 526 | MOG/RTBDN ratio | PRORT001552 | 3.90 | Protein ratios | Stromal / connective | 4 | 2 | 8 | 21 | |
| 527 | Fatty acids metabolites | METAB000052 | 3.90 | Metabolites | Hepatocyte | 20 | 2 | 4 | 18 | |
| 528 | Grey matter volume | NIMAG000023 | 3.89 | Neuroimaging | Stromal / connective | 53 | 0 | 0 | 0 | |
| 529 | GSTA4 levels | PROLV000941 | 3.89 | Protein levels | Adipose | 0 | 2 | 16 | 26 | |
| 530 | Heart rate, exercise | CARDI000017 | 3.87 | Cardiac | Muscle / cardiac | 19 | 6 | 12 | 25 | |
| 531 | Medication, antithrombotic | VASCU000033 | 3.87 | Vascular | Vascular | 37 | 4 | 10 | 12 | |
| 532 | FSTL3/SPON2 ratio | PRORT001182 | 3.87 | Protein ratios | Hepatocyte | 3 | 2 | 9 | 23 | |
| 533 | FYN levels | PROLV000843 | 3.85 | Protein levels | Muscle / cardiac | 0 | 3 | 12 | 32 | |
| 534 | White matter microstructure | NIMAG000013 | 3.84 | Neuroimaging | Neural / glial | 96 | 0 | 0 | 3 | |
| 535 | ADM/CLMP ratio | PRORT000045 | 3.84 | Protein ratios | B / plasma cell | 16 | 2 | 6 | 8 | |
| 536 | PINLYP levels | PROLV001562 | 3.83 | Protein levels | Myeloid | 66 | 4 | 10 | 14 | |
| 537 | Iron content, Pancreas | METBL000017 | 3.83 | Metabolic | Muscle / cardiac | 0 | 0 | 2 | 11 | |
| 538 | CLC/RNASE3 ratio | PRORT000625 | 3.82 | Protein ratios | Myeloid | 7 | 1 | 5 | 9 | |
| 539 | Cancer, Bladder | MALIG000009 | 3.82 | Malignancy | Cutaneous epithelium | 3 | 0 | 11 | 8 | |
| 540 | Gut microbial abundance, Alistipes | GASTR000018 | 3.82 | Gastrointestinal | Neural / glial | 0 | 6 | 11 | 30 | |
| 541 | VEGFD levels | PROLV002160 | 3.82 | Protein levels | Hepatocyte | 25 | 2 | 9 | 23 | |
| 542 | LEP levels | PROLV001199 | 3.81 | Protein levels | Neural / glial | 1 | 0 | 8 | 12 | |
| 543 | IGFBP6/SMOC2 ratio | PRORT001338 | 3.81 | Protein ratios | Adipose | 2 | 3 | 8 | 13 | |
| 544 | CD59 levels | PROLV000347 | 3.80 | Protein levels | Muscle / cardiac | 31 | 3 | 6 | 9 | |
| 545 | FLRT2 levels | PROLV000814 | 3.80 | Protein levels | Hepatocyte | 50 | 1 | 6 | 14 | |
| 546 | AHNAK levels | PROLV000062 | 3.80 | Protein levels | Lymphocyte | 17 | 2 | 12 | 33 | |
| 547 | CX3CL1 levels | PROLV000573 | 3.79 | Protein levels | Vascular | 67 | 2 | 4 | 14 | |
| 548 | HAVCR1 levels | PROLV000953 | 3.79 | Protein levels | Hepatocyte | 20 | 0 | 8 | 27 | |
| 549 | GRHPR levels | PROLV000932 | 3.79 | Protein levels | Stromal / connective | 2 | 5 | 18 | 40 | |
| 550 | EGFR levels | PROLV000687 | 3.78 | Protein levels | Adipose | 22 | 3 | 10 | 13 | |
| 551 | LRRC37A2 levels | PROLV001233 | 3.78 | Protein levels | B / plasma cell | 17 | 2 | 13 | 27 | |
| 552 | TRIM24 levels | PROLV002107 | 3.77 | Protein levels | Muscle / cardiac | 1 | 3 | 6 | 15 | |
| 553 | KCNA10 levels | PROLV001130 | 3.77 | Protein levels | Stromal / connective | 0 | 1 | 1 | 8 | |
| 554 | PDGFB/VEGFC ratio | PRORT001652 | 3.76 | Protein ratios | Neural / glial | 27 | 6 | 12 | 33 | |
| 555 | FABP4 levels | PROLV000754 | 3.75 | Protein levels | Stromal / connective | 8 | 0 | 3 | 6 | |
| 556 | THBS4 levels | PROLV002027 | 3.74 | Protein levels | Hepatocyte | 69 | 2 | 8 | 18 | |
| 557 | Hypothyroidism, subclinical in pregnancy | ENDOC000016 | 3.74 | Endocrine | Hematopoietic progenitor | 0 | 1 | 4 | 8 | |
| 558 | RELL1 levels | PROLV001721 | 3.74 | Protein levels | Neural / glial | 3 | 2 | 4 | 14 | |
| 559 | INSL4 levels | PROLV001092 | 3.74 | Protein levels | Muscle / cardiac | 3 | 2 | 4 | 12 | |
| 560 | MAMDC2 levels | PROLV001258 | 3.72 | Protein levels | Stromal / connective | 36 | 5 | 8 | 14 | |
| 561 | Arterial dissection | VASCU000003 | 3.72 | Vascular | Stromal / connective | 16 | 0 | 2 | 15 | |
| 562 | DLL1/EFEMP1 ratio | PRORT000914 | 3.69 | Protein ratios | Hepatocyte | 33 | 2 | 7 | 20 | |
| 563 | ATXN2L levels | PROLV000165 | 3.69 | Protein levels | Stromal / connective | 0 | 1 | 6 | 16 | |
| 564 | NPY levels | PROLV001429 | 3.69 | Protein levels | Hepatocyte | 131 | 2 | 6 | 21 | |
| 565 | MYLPF levels | PROLV001361 | 3.68 | Protein levels | Muscle / cardiac | 1 | 2 | 9 | 17 | |
| 566 | Benign neoplasm, Skin | MALIG000007 | 3.67 | Malignancy | Melanocyte | 10 | 0 | 5 | 10 | |
| 567 | SEZ6L2 levels | PROLV001842 | 3.66 | Protein levels | Myeloid | 148 | 2 | 6 | 12 | |
| 568 | SWAP70 levels | PROLV001983 | 3.66 | Protein levels | Hepatocyte | 3 | 2 | 9 | 12 | |
| 569 | MESD/VASH1 ratio | PRORT001518 | 3.64 | Protein ratios | Adipose | 9 | 4 | 9 | 19 | |
| 570 | Low hand grip strength | MSKEL000032 | 3.63 | Musculoskeletal | Muscle / cardiac | 1 | 4 | 10 | 21 | |
| 571 | Gut microbial abundance, Olsenella C | GASTR000030 | 3.61 | Gastrointestinal | Vascular | 0 | 4 | 10 | 24 | |
| 572 | CES1 levels | PROLV000405 | 3.59 | Protein levels | Hepatocyte | 148 | 1 | 8 | 13 | |
| 573 | TNR levels | PROLV002084 | 3.59 | Protein levels | Vascular | 90 | 3 | 8 | 15 | |
| 574 | Heme malignancy, Lymphoma | MALIG000044 | 3.59 | Malignancy | B / plasma cell | 27 | 2 | 6 | 28 | |
| 575 | Pregnancy complication, general | REPRO000029 | 3.58 | Reproductive | Hepatocyte | 3 | 2 | 6 | 12 | |
| 576 | DLL1/NOTCH1 ratio | PRORT000918 | 3.56 | Protein ratios | Vascular | 8 | 0 | 6 | 11 | |
| 577 | Valine | METAB000032 | 3.55 | Metabolites | Hepatocyte | 209 | 2 | 6 | 18 | |
| 578 | HYOU1/TGFBR3 ratio | PRORT001317 | 3.55 | Protein ratios | Hepatocyte | 27 | 2 | 8 | 23 | |
| 579 | SIL1 levels | PROLV001866 | 3.55 | Protein levels | Stromal / connective | 1 | 4 | 14 | 21 | |
| 580 | Brain MRI signal intensity | NIMAG000003 | 3.54 | Neuroimaging | Neural / glial | 143 | 4 | 7 | 15 | |
| 581 | Abnormal heart sounds | CARDI000051 | 3.54 | Cardiac | Muscle / cardiac | 19 | 4 | 6 | 14 | |
| 582 | AHCY/HSPA1A ratio | PRORT000055 | 3.53 | Protein ratios | Lymphocyte | 10 | 3 | 12 | 39 | |
| 583 | DKK3/LTBP2 ratio | PRORT000908 | 3.53 | Protein ratios | Neural / glial | 1 | 1 | 5 | 13 | |
| 584 | CD300LG/CD93 ratio | PRORT000433 | 3.51 | Protein ratios | Vascular | 3 | 2 | 5 | 16 | |
| 585 | CILP levels | PROLV000436 | 3.50 | Protein levels | Myeloid | 47 | 5 | 12 | 21 | |
| 586 | Brugada syndrome | CARDI000020 | 3.49 | Cardiac | Muscle / cardiac | 27 | 4 | 6 | 7 | |
| 587 | VWF levels | PROLV002182 | 3.47 | Protein levels | Vascular | 12 | 2 | 5 | 13 | |
| 588 | APOF levels | PROLV000125 | 3.47 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 589 | Cutaneous abscess | IMMUN000057 | 3.46 | Immunologic | Neural / glial | 0 | 2 | 7 | 15 | |
| 590 | Sepsis | IMMUN000071 | 3.45 | Immunologic | Vascular | — | 1 | 6 | 7 | |
| 591 | Leg impedance | BCOMP000016 | 3.45 | Body composition | Stromal / connective | 562 | 4 | 7 | 19 | |
| 592 | Benign neoplasm, Salivary gland | MALIG000006 | 3.45 | Malignancy | Neural / glial | 1 | 1 | 4 | 11 | |
| 593 | Atrial fibrillation and flutter | CARDI000019 | 3.45 | Cardiac | Muscle / cardiac | 758 | 2 | 4 | 8 | |
| 594 | BSG/PCDH1 ratio | PRORT000250 | 3.44 | Protein ratios | Neural / glial | 9 | 0 | 5 | 9 | |
| 595 | ADAMTS15/CLMP ratio | PRORT000024 | 3.43 | Protein ratios | Hepatocyte | 35 | 1 | 10 | 13 | |
| 596 | PDLIM7/SRC ratio | PRORT001655 | 3.43 | Protein ratios | Myeloid | 12 | 3 | 7 | 20 | |
| 597 | Acquired foot deformities | MSKEL000052 | 3.41 | Musculoskeletal | Stromal / connective | 38 | 2 | 5 | 12 | |
| 598 | PDE5A levels | PROLV001520 | 3.41 | Protein levels | Muscle / cardiac | 19 | 2 | 8 | 18 | |
| 599 | Cancer, Oesophagus | MALIG000021 | 3.40 | Malignancy | Salivary epithelium | 1 | 0 | 2 | 4 | |
| 600 | Alcoholic liver disease | HPBIL000033 | 3.40 | Hepatopancreatobiliary | Neural / glial | 1 | 3 | 14 | 15 | |
| 601 | CR2/TNFRSF13B ratio | PRORT000738 | 3.40 | Protein ratios | B / plasma cell | 32 | 3 | 9 | 15 | |
| 602 | OMD levels | PROLV001468 | 3.39 | Protein levels | Myeloid | 95 | 4 | 7 | 13 | |
| 603 | Ceramides | LIPID000065 | 3.39 | Lipids | Hepatocyte | 6 | 1 | 3 | 15 | |
| 604 | PRUNE2 levels | PROLV001652 | 3.39 | Protein levels | Hepatocyte | 23 | 1 | 3 | 15 | |
| 605 | FN1 levels | PROLV000819 | 3.37 | Protein levels | Myeloid | 76 | 5 | 15 | 27 | |
| 606 | ITGB1BP2/SKAP2 ratio | PRORT001387 | 3.35 | Protein ratios | Lymphocyte | 14 | 4 | 8 | 35 | |
| 607 | PSMG3 levels | PROLV001660 | 3.33 | Protein levels | Muscle / cardiac | 21 | 3 | 10 | 24 | |
| 608 | Brain neuroimaging quality metric | NIMAG000006 | 3.33 | Neuroimaging | Muscle / cardiac | 29 | 1 | 2 | 6 | |
| 609 | Peripheral nerve disorder | NEURO000031 | 3.32 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 610 | Paradoxical eczema | IMMUN000036 | 3.32 | Immunologic | Myeloid | 0 | 1 | 6 | 16 | |
| 611 | NCR3 levels | PROLV001383 | 3.32 | Protein levels | Adipose | — | 3 | 10 | 28 | |
| 612 | NCK2/VASH1 ratio | PRORT001575 | 3.31 | Protein ratios | Hepatocyte | 1 | 2 | 9 | 21 | |
| 613 | DAG1/PDGFB ratio | PRORT000851 | 3.30 | Protein ratios | Myeloid | 16 | 2 | 8 | 10 | |
| 614 | GPA33 levels | PROLV000918 | 3.30 | Protein levels | Vascular | 66 | 2 | 10 | 11 | |
| 615 | EIF4B/IPCEF1 ratio | PRORT001006 | 3.29 | Protein ratios | Muscle / cardiac | 2 | 4 | 14 | 22 | |
| 616 | GP6/LGALS8 ratio | PRORT001233 | 3.28 | Protein ratios | Hepatocyte | 5 | 5 | 10 | 28 | |
| 617 | CEP112 levels | PROLV000399 | 3.28 | Protein levels | Neural / glial | 0 | 2 | 5 | 11 | |
| 618 | AGRN/CRIM1 ratio | PRORT000047 | 3.28 | Protein ratios | Adipose | 8 | 3 | 11 | 13 | |
| 619 | PLXDC2 levels | PROLV001584 | 3.27 | Protein levels | Granulosa cell | 18 | 4 | 16 | 23 | |
| 620 | C1QTNF1/COL4A1 ratio | PRORT000263 | 3.25 | Protein ratios | Granulosa cell | 30 | 2 | 5 | 14 | |
| 621 | ITGA11 levels | PROLV001104 | 3.25 | Protein levels | Hepatocyte | 66 | 3 | 11 | 20 | |
| 622 | SLC27A4 levels | PROLV001878 | 3.25 | Protein levels | Muscle / cardiac | 1 | 3 | 9 | 20 | |
| 623 | CFI levels | PROLV000418 | 3.25 | Protein levels | Myeloid | 44 | 4 | 7 | 13 | |
| 624 | IGF1 levels | PROLV001025 | 3.24 | Protein levels | Hepatocyte | 1,341 | 1 | 7 | 13 | |
| 625 | Retinal thickness | OPHTH000043 | 3.23 | Ophthalmic | Neural / glial | 58 | 1 | 5 | 7 | |
| 626 | MMP10 levels | PROLV001322 | 3.23 | Protein levels | Epithelial | 12 | 0 | 6 | 7 | |
| 627 | Consultant specialty, urology | MISCL000020 | 3.22 | Miscellaneous | Neural / glial | 3 | 0 | 8 | 6 | |
| 628 | PON2 levels | PROLV001601 | 3.22 | Protein levels | Hepatocyte | 91 | 2 | 9 | 17 | |
| 629 | Implant | MISCL000025 | 3.21 | Miscellaneous | Stromal / connective | 0 | 0 | 0 | 0 | |
| 630 | SNX18 levels | PROLV001912 | 3.21 | Protein levels | Hepatocyte | 0 | 1 | 8 | 17 | |
| 631 | Atherosclerosis | VASCU000006 | 3.20 | Vascular | Hepatocyte | 177 | 2 | 10 | 20 | |
| 632 | Central serous chorioretinopathy | OPHTH000035 | 3.20 | Ophthalmic | Hepatocyte | 11 | 2 | 5 | 15 | |
| 633 | Medication, calcium channel blocker | VASCU000035 | 3.20 | Vascular | Vascular | 18 | 1 | 4 | 14 | |
| 634 | LBP levels | PROLV001188 | 3.19 | Protein levels | Hepatocyte | 18 | 2 | 7 | 22 | |
| 635 | COL4A1 levels | PROLV000490 | 3.18 | Protein levels | Hepatocyte | 117 | 3 | 10 | 16 | |
| 636 | Proline metabolites | METAB000013 | 3.15 | Metabolites | Granulosa cell | 2 | 0 | 5 | 9 | |
| 637 | CCL22/TIMP3 ratio | PRORT000352 | 3.13 | Protein ratios | Vascular | 5 | 2 | 7 | 19 | |
| 638 | Dorsopathy | MSKEL000075 | 3.13 | Musculoskeletal | Stromal / connective | 14 | 2 | 7 | 22 | |
| 639 | LAMA4/PDGFB ratio | PRORT001420 | 3.11 | Protein ratios | Neural / glial | 19 | 3 | 10 | 28 | |
| 640 | Vitamin E | METAB000079 | 3.11 | Metabolites | Hepatocyte | 2 | 1 | 5 | 12 | |
| 641 | FAP/LRRN1 ratio | PRORT001116 | 3.11 | Protein ratios | Muscle / cardiac | 42 | 5 | 15 | 34 | |
| 642 | IMPA1/TBCC ratio | PRORT001358 | 3.11 | Protein ratios | Muscle / cardiac | 0 | 1 | 6 | 13 | |
| 643 | Male-pattern baldness | DERMA000032 | 3.10 | Dermatologic | Stromal / connective | 74 | 0 | 4 | 6 | |
| 644 | Stroke | VASCU000017 | 3.09 | Vascular | Vascular | 37 | 2 | 4 | 11 | |
| 645 | Cancer, Breast | MALIG000011 | 3.09 | Malignancy | Cutaneous epithelium | 47 | 1 | 8 | 13 | |
| 646 | MYO9B levels | PROLV001362 | 3.09 | Protein levels | Myeloid | 14 | 1 | 7 | 10 | |
| 647 | CXCL5 levels | PROLV000584 | 3.08 | Protein levels | Platelet | 0 | 1 | 4 | 10 | |
| 648 | Medication, vasodilators | VASCU000041 | 3.08 | Vascular | Vascular | 3 | 2 | 5 | 5 | |
| 649 | OLR1 levels | PROLV001467 | 3.08 | Protein levels | Myeloid | 37 | 2 | 7 | 17 | |
| 650 | Anaemia | HEMAT000001 | 3.07 | Hematologic | Myeloid | 22 | 1 | 6 | 5 | |
| 651 | NBL1/TGFBR2 ratio | PRORT001573 | 3.06 | Protein ratios | Vascular | 18 | 1 | 7 | 15 | |
| 652 | SELE levels | PROLV001803 | 3.05 | Protein levels | Vascular | 55 | 2 | 4 | 14 | |
| 653 | FLT4/ICAM2 ratio | PRORT001166 | 3.05 | Protein ratios | Hepatocyte | 32 | 3 | 13 | 31 | |
| 654 | SERPINI1 levels | PROLV001836 | 3.04 | Protein levels | Myeloid | 23 | 1 | 6 | 9 | |
| 655 | ALDH1A1/SORD ratio | PRORT000081 | 3.03 | Protein ratios | Granulosa cell | 9 | 3 | 7 | 20 | |
| 656 | Chronic obstructive pulmonary disease, COPD | RESPI000009 | 3.03 | Respiratory | Neural / glial | 75 | 1 | 2 | 6 | |
| 657 | CA2/HMBS ratio | PRORT000275 | 3.03 | Protein ratios | Lymphocyte | 4 | 1 | 13 | 42 | |
| 658 | MMP3 levels | PROLV001325 | 3.02 | Protein levels | Myeloid | 51 | 1 | 6 | 8 | |
| 659 | Pyloric stenosis | GASTR000052 | 3.01 | Gastrointestinal | B / plasma cell | 0 | 0 | 6 | 6 | |
| 660 | PEPD levels | PROLV001536 | 3.01 | Protein levels | Myeloid | 66 | 2 | 7 | 7 | |
| 661 | LPCAT2 levels | PROLV001221 | 2.99 | Protein levels | Hepatocyte | 0 | 1 | 4 | 18 | |
| 662 | FCRL2/TNFRSF13B ratio | PRORT001132 | 2.99 | Protein ratios | B / plasma cell | 10 | 3 | 8 | 18 | |
| 663 | FKBP4/WWP2 ratio | PRORT001156 | 2.98 | Protein ratios | Hepatocyte | 10 | 5 | 12 | 18 | |
| 664 | Hearing loss, age-related | AUDIO000006 | 2.98 | Auditory | Neural / glial | 4 | 3 | 13 | 14 | |
| 665 | Occupational respiratory symptoms | RESPI000030 | 2.97 | Respiratory | Neural / glial | 0 | 1 | 4 | 11 | |
| 666 | NPL levels | PROLV001423 | 2.97 | Protein levels | Myeloid | 36 | 4 | 8 | 19 | |
| 667 | Pregnancy complication, premature | REPRO000033 | 2.97 | Reproductive | Neural / glial | 4 | 2 | 6 | 13 | |
| 668 | Hypertension | VASCU000027 | 2.96 | Vascular | Vascular | 668 | 3 | 5 | 11 | |
| 669 | CPXM1/LGMN ratio | PRORT000734 | 2.96 | Protein ratios | Platelet | 10 | 3 | 6 | 11 | |
| 670 | SPARCL1 levels | PROLV001924 | 2.96 | Protein levels | Hepatocyte | 112 | 2 | 9 | 18 | |
| 671 | CTSZ/NAAA ratio | PRORT000805 | 2.96 | Protein ratios | Stromal / connective | 45 | 2 | 10 | 14 | |
| 672 | Consultant specialty, general medicine | MISCL000016 | 2.95 | Miscellaneous | Neural / glial | 2 | 2 | 4 | 6 | |
| 673 | RGMB/SMOC2 ratio | PRORT001737 | 2.95 | Protein ratios | Myeloid | 30 | 4 | 10 | 19 | |
| 674 | Fibroblastic disorder | MSKEL000064 | 2.94 | Musculoskeletal | Stromal / connective | 49 | 3 | 6 | 10 | |
| 675 | Consultant specialty, gastroenterology | GASTR000007 | 2.94 | Gastrointestinal | Neural / glial | 0 | 5 | 12 | 16 | |
| 676 | Trauma exposure | PSYCH000054 | 2.93 | Psychiatric | Neural / glial | 32 | 2 | 6 | 14 | |
| 677 | PENK levels | PROLV001535 | 2.93 | Protein levels | Myeloid | 19 | 1 | 4 | 11 | |
| 678 | IMPACT levels | PROLV001085 | 2.92 | Protein levels | Muscle / cardiac | 1 | 5 | 11 | 38 | |
| 679 | Progesterone metabolite | METAB000072 | 2.91 | Metabolites | Hepatocyte | 13 | 1 | 6 | 18 | |
| 680 | Acute appendicitis | GASTR000009 | 2.91 | Gastrointestinal | Myeloid | 28 | 1 | 2 | 7 | |
| 681 | SETMAR levels | PROLV001839 | 2.91 | Protein levels | Myeloid | 63 | 2 | 8 | 10 | |
| 682 | MEGF9 levels | PROLV001294 | 2.90 | Protein levels | Hepatocyte | 93 | 2 | 11 | 23 | |
| 683 | FUT3 levels | PROLV000837 | 2.90 | Protein levels | Neural / glial | 2 | 2 | 5 | 17 | |
| 684 | FAM3C/NECTIN2 ratio | PRORT001115 | 2.89 | Protein ratios | Vascular | 19 | 1 | 12 | 10 | |
| 685 | Tumour marker CA125 | MALIG000037 | 2.88 | Malignancy | Melanocyte | 0 | 5 | 12 | 27 | |
| 686 | Ischaemic stroke | VASCU000015 | 2.86 | Vascular | Muscle / cardiac | 4 | 3 | 8 | 13 | |
| 687 | CD209/GP2 ratio | PRORT000397 | 2.83 | Protein ratios | Epithelial | 36 | 0 | 3 | 6 | |
| 688 | CLEC4D/HGF ratio | PRORT000655 | 2.83 | Protein ratios | Hepatocyte | 60 | 1 | 8 | 10 | |
| 689 | DNAJA2/HPCAL1 ratio | PRORT000922 | 2.83 | Protein ratios | Myeloid | 2 | 5 | 16 | 37 | |
| 690 | NFATC1/SPRY2 ratio | PRORT001586 | 2.83 | Protein ratios | Hepatocyte | 0 | 3 | 10 | 32 | |
| 691 | Atrophic skin disorder | DERMA000037 | 2.83 | Dermatologic | Lymphocyte | 12 | 2 | 8 | 14 | |
| 692 | EGF/MPIG6B ratio | PRORT000997 | 2.81 | Protein ratios | Myeloid | 1 | 3 | 12 | 21 | |
| 693 | CLK2 levels | PROLV000460 | 2.81 | Protein levels | Hepatocyte | 11 | 2 | 7 | 20 | |
| 694 | SEMA3G levels | PROLV001808 | 2.81 | Protein levels | Hepatocyte | 80 | 1 | 6 | 8 | |
| 695 | FCRL5/TNFRSF13B ratio | PRORT001136 | 2.80 | Protein ratios | B / plasma cell | 59 | 4 | 15 | 23 | |
| 696 | EGF/PPIB ratio | PRORT000998 | 2.77 | Protein ratios | Myeloid | 9 | 2 | 7 | 15 | |
| 697 | Oesophageal disorder | GASTR000050 | 2.76 | Gastrointestinal | Neural / glial | 15 | 2 | 10 | 21 | |
| 698 | Pulmonary nodule | RESPI000018 | 2.76 | Respiratory | Lymphocyte | 2 | 3 | 19 | 36 | |
| 699 | Cancer, Cervix | MALIG000012 | 2.76 | Malignancy | Lymphocyte | 23 | 0 | 4 | 30 | |
| 700 | ELOA levels | PROLV000701 | 2.76 | Protein levels | Neural / glial | 5 | 6 | 12 | 31 | |
| 701 | ESAM/SCARF1 ratio | PRORT001065 | 2.75 | Protein ratios | Myeloid | 27 | 1 | 4 | 9 | |
| 702 | Cardiovascular age gap | CARDI000001 | 2.74 | Cardiac | Muscle / cardiac | 27 | 3 | 6 | 16 | |
| 703 | APRT/PSME1 ratio | PRORT000137 | 2.74 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 33 | |
| 704 | ADGRG2 levels | PROLV000047 | 2.73 | Protein levels | Myeloid | 24 | 2 | 8 | 15 | |
| 705 | Cerebral aneurysm | VASCU000004 | 2.72 | Vascular | Vascular | 0 | 0 | 1 | 5 | |
| 706 | CD200R1 levels | PROLV000317 | 2.72 | Protein levels | Adipose | 54 | 2 | 5 | 14 | |
| 707 | COL9A1 levels | PROLV000493 | 2.71 | Protein levels | Stromal / connective | 7 | 6 | 17 | 22 | |
| 708 | COL6A3/TAFA5 ratio | PRORT000702 | 2.69 | Protein ratios | Hepatocyte | 31 | 5 | 7 | 24 | |
| 709 | Organic acid metabolites | METAB000067 | 2.69 | Metabolites | Pancreatic epithelium | 0 | 0 | 0 | 0 | |
| 710 | SAP18 levels | PROLV001775 | 2.68 | Protein levels | Hepatocyte | 3 | 3 | 7 | 13 | |
| 711 | CXCL3/CXCL5 ratio | PRORT000825 | 2.68 | Protein ratios | Myeloid | 8 | 3 | 14 | 24 | |
| 712 | Alport syndrome | NEPHR000003 | 2.67 | Nephrourologic | Lymphocyte | 3 | 3 | 4 | 20 | |
| 713 | CD27/FCRL5 ratio | PRORT000413 | 2.66 | Protein ratios | Neural / glial | 71 | 6 | 14 | 27 | |
| 714 | Household size | SOCIO000011 | 2.66 | Socioeconomic | Neural / glial | 0 | 4 | 9 | 17 | |
| 715 | EBV EA-D antibody | IMMUN000060 | 2.66 | Immunologic | Muscle / cardiac | 8 | 1 | 5 | 13 | |
| 716 | CTRB1 levels | PROLV000557 | 2.66 | Protein levels | Pancreatic epithelium | 159 | 0 | 3 | 4 | |
| 717 | FABP2/LGALS4 ratio | PRORT001098 | 2.65 | Protein ratios | Hepatocyte | 25 | 1 | 9 | 13 | |
| 718 | Family history, breast cancer | MALIG000038 | 2.64 | Malignancy | Myeloid | 0 | 1 | 4 | 8 | |
| 719 | DAB2/ZBTB16 ratio | PRORT000843 | 2.64 | Protein ratios | Muscle / cardiac | 11 | 4 | 8 | 17 | |
| 720 | JAM2/TNFRSF14 ratio | PRORT001399 | 2.63 | Protein ratios | Platelet | 2 | 6 | 12 | 25 | |
| 721 | SIGLEC9 levels | PROLV001865 | 2.63 | Protein levels | Hepatocyte | 118 | 1 | 6 | 11 | |
| 722 | Carotid intima-media thickness | VASCU000053 | 2.63 | Vascular | Adipose | 15 | 2 | 5 | 12 | |
| 723 | Whole body impedance | BCOMP000007 | 2.61 | Body composition | Stromal / connective | 553 | 5 | 7 | 15 | |
| 724 | PSMD9/UBAC1 ratio | PRORT001712 | 2.61 | Protein ratios | Muscle / cardiac | 4 | 1 | 4 | 8 | |
| 725 | APP/LAMA4 ratio | PRORT000127 | 2.61 | Protein ratios | Lymphocyte | 7 | 3 | 9 | 26 | |
| 726 | Corrective lens use | OPHTH000032 | 2.61 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 727 | Cardiac procedure, angioplasty | VASCU000057 | 2.61 | Vascular | Vascular | 102 | 4 | 10 | 20 | |
| 728 | GGT1/IL1RL2 ratio | PRORT001213 | 2.60 | Protein ratios | Hepatocyte | 23 | 2 | 11 | 16 | |
| 729 | Pneumoconiosis | RESPI000015 | 2.60 | Respiratory | Stromal / connective | 0 | 1 | 5 | 10 | |
| 730 | BLVRB/HAGH ratio | PRORT000241 | 2.60 | Protein ratios | Neural / glial | 22 | 2 | 7 | 8 | |
| 731 | SLIT2 levels | PROLV001887 | 2.60 | Protein levels | Neural / glial | 0 | 1 | 7 | 15 | |
| 732 | Ventricular volume | CARDI000015 | 2.59 | Cardiac | Muscle / cardiac | 83 | 2 | 7 | 15 | |
| 733 | MANF/PTPN6 ratio | PRORT001479 | 2.58 | Protein ratios | Muscle / cardiac | 9 | 1 | 5 | 13 | |
| 734 | GPHA2 levels | PROLV000922 | 2.57 | Protein levels | Stromal / connective | 9 | 0 | 2 | 3 | |
| 735 | Urinary incontinence | NEPHR000014 | 2.57 | Nephrourologic | Epithelial | 1 | 1 | 9 | 9 | |
| 736 | Social and economic stability | SOCIO000028 | 2.56 | Socioeconomic | Neural / glial | 0 | 4 | 7 | 26 | |
| 737 | ADGRD1 levels | PROLV000041 | 2.56 | Protein levels | Hepatocyte | 47 | 5 | 12 | 15 | |
| 738 | CXADR/GGT1 ratio | PRORT000812 | 2.55 | Protein ratios | Hepatocyte | 17 | 1 | 4 | 10 | |
| 739 | CCL17/THPO ratio | PRORT000347 | 2.55 | Protein ratios | Myeloid | 11 | 4 | 10 | 37 | |
| 740 | Gastrointestinal endoscopy | GASTR000042 | 2.55 | Gastrointestinal | Neural / glial | 13 | 2 | 8 | 11 | |
| 741 | Fall risk | MSKEL000043 | 2.54 | Musculoskeletal | Stromal / connective | 1 | 0 | 5 | 10 | |
| 742 | TCTN3 levels | PROLV002005 | 2.54 | Protein levels | Hepatocyte | 89 | 3 | 10 | 20 | |
| 743 | Dietary change, none | DTSUP000005 | 2.54 | Diet and Supplement | Neural / glial | 19 | 3 | 12 | 8 | |
| 744 | CDH5/TEK ratio | PRORT000561 | 2.54 | Protein ratios | Vascular | 42 | 2 | 8 | 11 | |
| 745 | Leucine | METAB000025 | 2.54 | Metabolites | Hepatocyte | 24 | 3 | 8 | 21 | |
| 746 | SMOC1 levels | PROLV001899 | 2.53 | Protein levels | Hepatocyte | 129 | 1 | 6 | 15 | |
| 747 | SNX9/STIP1 ratio | PRORT001801 | 2.53 | Protein ratios | Vascular | 0 | 6 | 15 | 31 | |
| 748 | DNPH1/PDGFB ratio | PRORT000936 | 2.53 | Protein ratios | Hepatocyte | 5 | 4 | 7 | 23 | |
| 749 | AKT1S1/MAX ratio | PRORT000065 | 2.52 | Protein ratios | Myeloid | 3 | 3 | 10 | 12 | |
| 750 | TFPI levels | PROLV002015 | 2.52 | Protein levels | Hepatocyte | 121 | 2 | 8 | 15 | |
| 751 | PLA2G2A levels | PROLV001568 | 2.51 | Protein levels | Myeloid | 20 | 3 | 9 | 17 | |
| 752 | DCBLD2 levels | PROLV000600 | 2.51 | Protein levels | Hepatocyte | 264 | 3 | 13 | 20 | |
| 753 | Cancer, General | MALIG000015 | 2.50 | Malignancy | Myeloid | 29 | 0 | 1 | 2 | |
| 754 | CA1/TGM2 ratio | PRORT000270 | 2.50 | Protein ratios | Hematopoietic progenitor | 1 | 6 | 9 | 12 | |
| 755 | SCRG1 levels | PROLV001793 | 2.50 | Protein levels | Stromal / connective | 1 | 0 | 6 | 7 | |
| 756 | LTBP2/PDGFRA ratio | PRORT001465 | 2.49 | Protein ratios | Myeloid | 4 | 3 | 9 | 8 | |
| 757 | TP53I3 levels | PROLV002091 | 2.49 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 758 | ANG/F9 ratio | PRORT000089 | 2.49 | Protein ratios | Hepatocyte | 31 | 1 | 6 | 6 | |
| 759 | Gut microbial abundance, Prevotella | GASTR000031 | 2.49 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 11 | |
| 760 | WNT9A levels | PROLV002194 | 2.49 | Protein levels | Muscle / cardiac | 20 | 2 | 6 | 20 | |
| 761 | MB levels | PROLV001281 | 2.49 | Protein levels | Muscle / cardiac | 26 | 3 | 4 | 11 | |
| 762 | Triglycerides | LIPID000039 | 2.48 | Lipids | Hepatocyte | 33 | 1 | 3 | 13 | |
| 763 | Body fat percentage, hormone-adjusted | BCOMP000001 | 2.47 | Body composition | Hepatocyte | 237 | 2 | 6 | 9 | |
| 764 | PRTG levels | PROLV001650 | 2.46 | Protein levels | Hepatocyte | 34 | 4 | 11 | 17 | |
| 765 | GAL levels | PROLV000847 | 2.46 | Protein levels | Hepatocyte | 129 | 1 | 11 | 16 | |
| 766 | COLEC12/NBL1 ratio | PRORT000704 | 2.45 | Protein ratios | Myeloid | 12 | 1 | 5 | 4 | |
| 767 | Lung volume | RESPI000022 | 2.45 | Respiratory | Myeloid | 4 | 3 | 7 | 12 | |
| 768 | CCL11 levels | PROLV000278 | 2.44 | Protein levels | Vascular | 47 | 0 | 1 | 5 | |
| 769 | CSNK1D levels | PROLV000542 | 2.44 | Protein levels | Lymphocyte | 32 | 2 | 12 | 32 | |
| 770 | ENG/NCAM2 ratio | PRORT001017 | 2.44 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 6 | 15 | |
| 771 | NCAM1 levels | PROLV001377 | 2.43 | Protein levels | Muscle / cardiac | 119 | 4 | 11 | 24 | |
| 772 | SUMF1 levels | PROLV001975 | 2.41 | Protein levels | Lymphocyte | 0 | 4 | 12 | 28 | |
| 773 | Medication, peripheral vascular disease | VASCU000039 | 2.41 | Vascular | Myeloid | 0 | 1 | 5 | 9 | |
| 774 | LAMP1 levels | PROLV001180 | 2.40 | Protein levels | Myeloid | 47 | 3 | 9 | 19 | |
| 775 | Trunk fat percentage | BCOMP000018 | 2.40 | Body composition | Neural / glial | 276 | 3 | 10 | 17 | |
| 776 | Abdominal adiposity | BCOMP000003 | 2.40 | Body composition | Neural / glial | 18 | 2 | 6 | 21 | |
| 777 | CELSR2 levels | PROLV000398 | 2.39 | Protein levels | Muscle / cardiac | 14 | 2 | 9 | 15 | |
| 778 | DBNL/VASH1 ratio | PRORT000869 | 2.38 | Protein ratios | Muscle / cardiac | 0 | 2 | 9 | 14 | |
| 779 | CA11 levels | PROLV000240 | 2.38 | Protein levels | Adipose | 0 | 3 | 6 | 23 | |
| 780 | AMBP/EFEMP1 ratio | PRORT000085 | 2.38 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 11 | |
| 781 | Cancer, Colorectal | MALIG000013 | 2.38 | Malignancy | Epithelial | 27 | 0 | 3 | 2 | |
| 782 | FGFBP2 levels | PROLV000799 | 2.38 | Protein levels | Myeloid | 82 | 3 | 11 | 17 | |
| 783 | Foot surgery | MSKEL000046 | 2.37 | Musculoskeletal | Hematopoietic progenitor | 2 | 2 | 6 | 12 | |
| 784 | MAVS/MED18 ratio | PRORT001495 | 2.37 | Protein ratios | Lymphocyte | 20 | 6 | 15 | 39 | |
| 785 | GFRAL levels | PROLV000879 | 2.36 | Protein levels | Vascular | 26 | 2 | 9 | 20 | |
| 786 | FKBP5/ZBTB16 ratio | PRORT001160 | 2.36 | Protein ratios | Muscle / cardiac | 21 | 1 | 4 | 12 | |
| 787 | Hippocampal volume | NIMAG000024 | 2.36 | Neuroimaging | Stromal / connective | 0 | 0 | 0 | 0 | |
| 788 | CXCL17 levels | PROLV000582 | 2.36 | Protein levels | Vascular | 72 | 1 | 8 | 16 | |
| 789 | Tyrosine | METAB000031 | 2.36 | Metabolites | Hepatocyte | 258 | 1 | 5 | 10 | |
| 790 | COLEC12/TAFA5 ratio | PRORT000706 | 2.35 | Protein ratios | B / plasma cell | 13 | 1 | 6 | 11 | |
| 791 | PIK3AP1 levels | PROLV001557 | 2.35 | Protein levels | Hematopoietic progenitor | 18 | 3 | 9 | 27 | |
| 792 | PTGES2 levels | PROLV001665 | 2.33 | Protein levels | Myeloid | 1 | 3 | 13 | 21 | |
| 793 | IGDCC4 levels | PROLV001024 | 2.33 | Protein levels | Myeloid | 46 | 4 | 11 | 16 | |
| 794 | CXCL10/WARS ratio | PRORT000815 | 2.33 | Protein ratios | Hepatocyte | 4 | 2 | 9 | 17 | |
| 795 | NPTX2 levels | PROLV001427 | 2.32 | Protein levels | Myeloid | 12 | 3 | 10 | 16 | |
| 796 | CCNE1 levels | PROLV000306 | 2.32 | Protein levels | B / plasma cell | 8 | 0 | 6 | 17 | |
| 797 | EPHA1 levels | PROLV000716 | 2.32 | Protein levels | Hepatocyte | 108 | 2 | 9 | 15 | |
| 798 | Medication, anticoagulant | VASCU000030 | 2.31 | Vascular | Muscle / cardiac | 85 | 2 | 7 | 18 | |
| 799 | CA2/TGM2 ratio | PRORT000278 | 2.31 | Protein ratios | Epithelial | 17 | 3 | 7 | 15 | |
| 800 | TALDO1 levels | PROLV001991 | 2.31 | Protein levels | Lymphocyte | 8 | 3 | 10 | 40 | |
| 801 | AKT3 levels | PROLV000076 | 2.31 | Protein levels | Platelet | 10 | 5 | 10 | 16 | |
| 802 | NOTCH3 levels | PROLV001418 | 2.29 | Protein levels | Hepatocyte | 166 | 2 | 12 | 29 | |
| 803 | CTSF/CTSV ratio | PRORT000800 | 2.29 | Protein ratios | Hepatocyte | 55 | 1 | 7 | 9 | |
| 804 | Chronic kidney disease | NEPHR000001 | 2.29 | Nephrourologic | Hepatocyte | 63 | 1 | 4 | 8 | |
| 805 | ART3 levels | PROLV000147 | 2.28 | Protein levels | Muscle / cardiac | 82 | 2 | 6 | 7 | |
| 806 | CBLN4/RET ratio | PRORT000326 | 2.28 | Protein ratios | Vascular | 13 | 1 | 8 | 16 | |
| 807 | Cardiac conduction disorder | CARDI000030 | 2.28 | Cardiac | Muscle / cardiac | 14 | 3 | 6 | 13 | |
| 808 | LGMN/SPINT2 ratio | PRORT001457 | 2.28 | Protein ratios | Platelet | 0 | 1 | 5 | 7 | |
| 809 | LTBP2/MYOC ratio | PRORT001464 | 2.27 | Protein ratios | Neural / glial | 0 | 3 | 8 | 16 | |
| 810 | HNRNPUL1 levels | PROLV000983 | 2.26 | Protein levels | Lymphocyte | 15 | 4 | 11 | 41 | |
| 811 | PTPRS levels | PROLV001681 | 2.26 | Protein levels | Lymphocyte | 21 | 2 | 9 | 37 | |
| 812 | PLIN3 levels | PROLV001579 | 2.26 | Protein levels | Muscle / cardiac | 0 | 6 | 11 | 22 | |
| 813 | HJV levels | PROLV000971 | 2.26 | Protein levels | Hepatocyte | 12 | 4 | 12 | 35 | |
| 814 | Cardiac imaging | CARDI000011 | 2.26 | Cardiac | Muscle / cardiac | 20 | 2 | 6 | 19 | |
| 815 | Liver fat | HPBIL000023 | 2.25 | Hepatopancreatobiliary | Neural / glial | 33 | 2 | 5 | 16 | |
| 816 | CD40LG/TNFSF14 ratio | PRORT000454 | 2.25 | Protein ratios | Hepatocyte | 11 | 5 | 17 | 43 | |
| 817 | ALPI levels | PROLV000082 | 2.24 | Protein levels | Stromal / connective | 4 | 0 | 4 | 21 | |
| 818 | MYOC levels | PROLV001363 | 2.24 | Protein levels | Vascular | 33 | 0 | 5 | 12 | |
| 819 | COL6A3/SMOC2 ratio | PRORT000700 | 2.24 | Protein ratios | Adipose | 34 | 4 | 6 | 17 | |
| 820 | FCRL2/LY9 ratio | PRORT001130 | 2.24 | Protein ratios | B / plasma cell | 27 | 2 | 8 | 38 | |
| 821 | Jaw relationship anomaly | DENTA000007 | 2.23 | Dental | Neural / glial | 0 | 1 | 5 | 12 | |
| 822 | SPINK2 levels | PROLV001928 | 2.22 | Protein levels | Lymphocyte | 29 | 4 | 16 | 31 | |
| 823 | CD58/MCAM ratio | PRORT000476 | 2.22 | Protein ratios | Adipose | 2 | 1 | 6 | 12 | |
| 824 | Brain functional connectivity | NIMAG000002 | 2.22 | Neuroimaging | Neural / glial | 0 | 0 | 0 | 0 | |
| 825 | CLEC4D levels | PROLV000452 | 2.22 | Protein levels | Myeloid | 21 | 1 | 5 | 13 | |
| 826 | FABP1/FABP2 ratio | PRORT001094 | 2.22 | Protein ratios | Hepatocyte | 10 | 2 | 6 | 16 | |
| 827 | Brain functional activity | NIMAG000001 | 2.21 | Neuroimaging | Hepatocyte | 9 | 0 | 1 | 6 | |
| 828 | FLT4 levels | PROLV000818 | 2.21 | Protein levels | Vascular | 123 | 4 | 11 | 19 | |
| 829 | NEFL levels | PROLV001389 | 2.20 | Protein levels | Hepatocyte | 16 | 2 | 7 | 16 | |
| 830 | EPCAM levels | PROLV000715 | 2.20 | Protein levels | Vascular | 30 | 1 | 7 | 12 | |
| 831 | Acquired absence of organs | MISCL000027 | 2.19 | Miscellaneous | Neural / glial | 1 | 4 | 12 | 15 | |
| 832 | DKK1/PDGFA ratio | PRORT000898 | 2.19 | Protein ratios | Hematopoietic progenitor | 4 | 3 | 10 | 26 | |
| 833 | Ketone bodies | METAB000056 | 2.19 | Metabolites | Hepatocyte | 118 | 1 | 6 | 7 | |
| 834 | Viral haemorrhagic fever | IMMUN000075 | 2.19 | Immunologic | Muscle / cardiac | 13 | 2 | 10 | 31 | |
| 835 | Chronic bronchitis | RESPI000010 | 2.18 | Respiratory | Neural / glial | 1 | 1 | 2 | 7 | |
| 836 | Meniscus surgery | MSKEL000050 | 2.18 | Musculoskeletal | Lymphocyte | 2 | 2 | 6 | 23 | |
| 837 | Fasciitis | MSKEL000063 | 2.17 | Musculoskeletal | Stromal / connective | 16 | 1 | 3 | 8 | |
| 838 | WIF1 levels | PROLV002193 | 2.17 | Protein levels | Vascular | 116 | 2 | 7 | 15 | |
| 839 | CDH6/NTRK2 ratio | PRORT000562 | 2.16 | Protein ratios | Muscle / cardiac | 4 | 3 | 13 | 28 | |
| 840 | PSAP levels | PROLV001653 | 2.16 | Protein levels | Myeloid | 52 | 2 | 7 | 16 | |
| 841 | Carotid plaque | VASCU000054 | 2.15 | Vascular | Vascular | 2 | 1 | 4 | 9 | |
| 842 | GZMA levels | PROLV000947 | 2.15 | Protein levels | Myeloid | 161 | 3 | 5 | 15 | |
| 843 | Cystatin C | NEPHR000019 | 2.15 | Nephrourologic | Myeloid | 898 | 1 | 7 | 9 | |
| 844 | RABGAP1L levels | PROLV001702 | 2.15 | Protein levels | Muscle / cardiac | 7 | 3 | 10 | 23 | |
| 845 | KLB levels | PROLV001148 | 2.15 | Protein levels | Hepatocyte | 138 | 1 | 9 | 23 | |
| 846 | DBNL/HSPA1A ratio | PRORT000867 | 2.14 | Protein ratios | Muscle / cardiac | 3 | 2 | 11 | 18 | |
| 847 | CXCL3/MGLL ratio | PRORT000826 | 2.13 | Protein ratios | Platelet | 0 | 2 | 5 | 16 | |
| 848 | ZNF830 levels | PROLV002212 | 2.12 | Protein levels | B / plasma cell | 4 | 4 | 11 | 30 | |
| 849 | Tubulointerstitial kidney disease | NEPHR000025 | 2.12 | Nephrourologic | Lymphocyte | 2 | 0 | 8 | 17 | |
| 850 | Breast size | BMORP000007 | 2.11 | Body morphology | Hepatocyte | 0 | 1 | 4 | 14 | |
| 851 | DAB2/ERBIN ratio | PRORT000835 | 2.11 | Protein ratios | Muscle / cardiac | 0 | 5 | 15 | 36 | |
| 852 | AZU1/MPO ratio | PRORT000185 | 2.10 | Protein ratios | Myeloid | 8 | 1 | 4 | 8 | |
| 853 | F5 levels | PROLV000747 | 2.10 | Protein levels | Muscle / cardiac | 0 | 3 | 14 | 28 | |
| 854 | Bone mineral density, childhood | MSKEL000003 | 2.09 | Musculoskeletal | Muscle / cardiac | 1 | 1 | 6 | 5 | |
| 855 | CD93 levels | PROLV000362 | 2.09 | Protein levels | Granulosa cell | 47 | 1 | 5 | 10 | |
| 856 | GALNT3 levels | PROLV000850 | 2.09 | Protein levels | Vascular | 35 | 2 | 5 | 8 | |
| 857 | Cardiac strain rate | CARDI000006 | 2.08 | Cardiac | Muscle / cardiac | 0 | 2 | 3 | 5 | |
| 858 | NTRK3 levels | PROLV001448 | 2.08 | Protein levels | Myeloid | 68 | 2 | 4 | 7 | |
| 859 | CAMSAP1 levels | PROLV000260 | 2.08 | Protein levels | Myeloid | 2 | 2 | 2 | 10 | |
| 860 | CALCOCO1/DCTN1 ratio | PRORT000294 | 2.07 | Protein ratios | Muscle / cardiac | 0 | 3 | 9 | 21 | |
| 861 | Cancer, Lung | MALIG000019 | 2.07 | Malignancy | Lymphocyte | 41 | 0 | 1 | 3 | |
| 862 | IGFBP6 levels | PROLV001032 | 2.07 | Protein levels | Hepatocyte | 24 | 1 | 5 | 7 | |
| 863 | GNS levels | PROLV000907 | 2.06 | Protein levels | Myeloid | 0 | 1 | 7 | 13 | |
| 864 | KIFBP/TBC1D23 ratio | PRORT001405 | 2.05 | Protein ratios | Muscle / cardiac | 3 | 4 | 10 | 24 | |
| 865 | KRT5 levels | PROLV001167 | 2.04 | Protein levels | Cutaneous epithelium | 11 | 0 | 11 | 17 | |
| 866 | Testicular dysfunction | REPRO000016 | 2.04 | Reproductive | Hepatocyte | 14 | 3 | 12 | 33 | |
| 867 | RABEP1 levels | PROLV001701 | 2.03 | Protein levels | Vascular | 10 | 4 | 10 | 41 | |
| 868 | Haemoglobin | HEMAT000007 | 2.03 | Hematologic | Hepatocyte | 2,197 | 1 | 4 | 10 | |
| 869 | BTN2A1/LILRB4 ratio | PRORT000258 | 2.03 | Protein ratios | Myeloid | 77 | 3 | 10 | 14 | |
| 870 | Thrombophlebitis | VASCU000063 | 2.02 | Vascular | Hepatocyte | 61 | 1 | 4 | 9 | |
| 871 | DAB2/VASH1 ratio | PRORT000842 | 2.02 | Protein ratios | Hepatocyte | 1 | 2 | 11 | 23 | |
| 872 | AGRP/NPY ratio | PRORT000050 | 2.01 | Protein ratios | Hepatocyte | 28 | 1 | 9 | 10 | |
| 873 | IL15RA levels | PROLV001049 | 2.00 | Protein levels | Lymphocyte | 1 | 0 | 7 | 10 | |
| 874 | Pre-eclampsia | VASCU000047 | 2.00 | Vascular | Myeloid | 7 | 2 | 3 | 7 | |
| 875 | CLIP2 levels | PROLV000459 | 1.99 | Protein levels | Vascular | 19 | 1 | 5 | 9 | |
| 876 | WFIKKN1 levels | PROLV002191 | 1.99 | Protein levels | Vascular | 125 | 2 | 7 | 15 | |
| 877 | PODXL levels | PROLV001595 | 1.98 | Protein levels | Vascular | 18 | 1 | 5 | 12 | |
| 878 | CRIM1/NRP2 ratio | PRORT000760 | 1.97 | Protein ratios | Vascular | 11 | 3 | 12 | 17 | |
| 879 | SRPK2 levels | PROLV001944 | 1.97 | Protein levels | Vascular | 3 | 3 | 9 | 32 | |
| 880 | Xenobiotic metabolites | METAB000080 | 1.97 | Metabolites | Hepatocyte | 26 | 1 | 3 | 11 | |
| 881 | APP/NID1 ratio | PRORT000128 | 1.96 | Protein ratios | Muscle / cardiac | 4 | 3 | 8 | 21 | |
| 882 | EDAR/YES1 ratio | PRORT000985 | 1.96 | Protein ratios | Myeloid | 30 | 5 | 12 | 27 | |
| 883 | TBC1D5 levels | PROLV001997 | 1.96 | Protein levels | Myeloid | 7 | 2 | 6 | 19 | |
| 884 | Falling risk | MISCL000040 | 1.96 | Miscellaneous | Neural / glial | 1 | 3 | 5 | 5 | |
| 885 | LILRB4 levels | PROLV001215 | 1.95 | Protein levels | Myeloid | 162 | 2 | 8 | 19 | |
| 886 | PTPN6/YES1 ratio | PRORT001720 | 1.94 | Protein ratios | Hepatocyte | 18 | 2 | 12 | 17 | |
| 887 | XRCC4 levels | PROLV002200 | 1.93 | Protein levels | Myeloid | 0 | 4 | 9 | 17 | |
| 888 | ACYP1 levels | PROLV000021 | 1.93 | Protein levels | Lymphocyte | 14 | 2 | 12 | 34 | |
| 889 | CDKN2D/ITGB1BP2 ratio | PRORT000578 | 1.93 | Protein ratios | Hematopoietic progenitor | 17 | 5 | 12 | 35 | |
| 890 | DPP6/SEZ6L2 ratio | PRORT000948 | 1.92 | Protein ratios | Myeloid | 37 | 4 | 14 | 16 | |
| 891 | ATXN10 levels | PROLV000164 | 1.91 | Protein levels | Vascular | 7 | 3 | 9 | 20 | |
| 892 | Medication, ACE inhibitor | VASCU000028 | 1.91 | Vascular | Vascular | 12 | 0 | 2 | 3 | |
| 893 | ADAMTS13 levels | PROLV000031 | 1.91 | Protein levels | Hepatocyte | 161 | 2 | 10 | 17 | |
| 894 | ITGB1/TFPI ratio | PRORT001381 | 1.90 | Protein ratios | Hepatocyte | 52 | 1 | 14 | 13 | |
| 895 | AAMDC levels | PROLV000004 | 1.90 | Protein levels | Myeloid | 19 | 1 | 5 | 7 | |
| 896 | COCH levels | PROLV000482 | 1.89 | Protein levels | Hematopoietic progenitor | 30 | 3 | 5 | 13 | |
| 897 | Kidney transplant | NEPHR000023 | 1.88 | Nephrourologic | Muscle / cardiac | 0 | 1 | 12 | 19 | |
| 898 | Bicarbonate | METAB000042 | 1.88 | Metabolites | Renal epithelium | 656 | 1 | 6 | 6 | |
| 899 | Sphingomyelins | LIPID000072 | 1.88 | Lipids | Hepatocyte | 272 | 1 | 2 | 8 | |
| 900 | FAM171B levels | PROLV000761 | 1.87 | Protein levels | Muscle / cardiac | 12 | 2 | 4 | 8 | |
| 901 | DPP7 levels | PROLV000648 | 1.86 | Protein levels | Muscle / cardiac | 129 | 4 | 14 | 27 | |
| 902 | MZT1 levels | PROLV001367 | 1.84 | Protein levels | Vascular | 0 | 2 | 7 | 12 | |
| 903 | NOS3 levels | PROLV001415 | 1.84 | Protein levels | Myeloid | 58 | 5 | 9 | 18 | |
| 904 | EREG/MPI ratio | PRORT001057 | 1.84 | Protein ratios | Myeloid | 11 | 4 | 8 | 13 | |
| 905 | Supplement use, mineral or vitamin | DTSUP000026 | 1.84 | Diet and Supplement | Neural / glial | 7 | 5 | 9 | 22 | |
| 906 | NID1/TIMP3 ratio | PRORT001590 | 1.84 | Protein ratios | Vascular | 24 | 1 | 7 | 11 | |
| 907 | VIT levels | PROLV002162 | 1.83 | Protein levels | Myeloid | 11 | 6 | 14 | 27 | |
| 908 | ITPA levels | PROLV001121 | 1.83 | Protein levels | Muscle / cardiac | 0 | 3 | 7 | 21 | |
| 909 | Congenital cardiovascular malformations | CARDI000031 | 1.82 | Cardiac | Vascular | 0 | 4 | 10 | 28 | |
| 910 | Coffee preference | DTSUP000002 | 1.81 | Diet and Supplement | Neural / glial | 139 | 4 | 10 | 14 | |
| 911 | Family history, coronary artery disease | VASCU000021 | 1.81 | Vascular | Vascular | 26 | 0 | 2 | 7 | |
| 912 | FCN1 levels | PROLV000781 | 1.81 | Protein levels | Myeloid | 95 | 2 | 8 | 18 | |
| 913 | ITGA2 levels | PROLV001105 | 1.81 | Protein levels | Vascular | 76 | 3 | 13 | 27 | |
| 914 | Aplastic anaemia | HEMAT000004 | 1.81 | Hematologic | Muscle / cardiac | 0 | 2 | 5 | 18 | |
| 915 | PDGFB/TIMP3 ratio | PRORT001648 | 1.81 | Protein ratios | Hepatocyte | 15 | 1 | 8 | 25 | |
| 916 | GRP levels | PROLV000934 | 1.80 | Protein levels | Granulosa cell | 6 | 2 | 3 | 7 | |
| 917 | Medication, anti-asthmatic | IMMUN000082 | 1.80 | Immunologic | Lymphocyte | 36 | 1 | 8 | 22 | |
| 918 | Operation, urological | NEPHR000016 | 1.80 | Nephrourologic | Vascular | 16 | 0 | 6 | 18 | |
| 919 | Ventricular function | CARDI000008 | 1.79 | Cardiac | Muscle / cardiac | 84 | 2 | 4 | 12 | |
| 920 | Blood urea nitrogen | NEPHR000017 | 1.79 | Nephrourologic | Renal epithelium | 631 | 0 | 3 | 6 | |
| 921 | RAPGEF2 levels | PROLV001705 | 1.79 | Protein levels | Stromal / connective | 2 | 2 | 17 | 40 | |
| 922 | BRAP levels | PROLV000212 | 1.79 | Protein levels | Vascular | 9 | 2 | 7 | 12 | |
| 923 | Liver iron content | HPBIL000024 | 1.78 | Hepatopancreatobiliary | Hematopoietic progenitor | 23 | 1 | 9 | 14 | |
| 924 | ZBTB16 levels | PROLV002209 | 1.78 | Protein levels | Muscle / cardiac | 43 | 3 | 6 | 15 | |
| 925 | ASPN levels | PROLV000153 | 1.78 | Protein levels | Stromal / connective | 10 | 4 | 12 | 35 | |
| 926 | Knee derangements | MSKEL000016 | 1.78 | Musculoskeletal | Stromal / connective | 5 | 1 | 2 | 7 | |
| 927 | Cancer, Endometrium | MALIG000014 | 1.78 | Malignancy | Lymphocyte | 8 | 2 | 14 | 50 | |
| 928 | Atrioventricular block | CARDI000028 | 1.78 | Cardiac | Muscle / cardiac | 7 | 4 | 6 | 19 | |
| 929 | F9/FETUB ratio | PRORT001090 | 1.77 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 15 | |
| 930 | A4GALT levels | PROLV000002 | 1.77 | Protein levels | Vascular | 7 | 0 | 2 | 1 | |
| 931 | EGLN1 levels | PROLV000688 | 1.77 | Protein levels | Lymphocyte | 10 | 5 | 9 | 39 | |
| 932 | Purine metabolites | METAB000062 | 1.77 | Metabolites | Hepatocyte | 3 | 1 | 5 | 13 | |
| 933 | Gut microbial abundance, CAG-269 | GASTR000021 | 1.77 | Gastrointestinal | Lymphocyte | 0 | 1 | 4 | 7 | |
| 934 | Optic disc morphology | OPHTH000030 | 1.76 | Ophthalmic | Vascular | 8 | 1 | 10 | 15 | |
| 935 | Hearing loss | AUDIO000013 | 1.75 | Auditory | Neural / glial | 54 | 1 | 3 | 11 | |
| 936 | ICAM5 levels | PROLV001008 | 1.74 | Protein levels | Myeloid | 6 | 0 | 3 | 9 | |
| 937 | Dietary change | DTSUP000006 | 1.74 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 0 | |
| 938 | Ganglion cyst | MSKEL000065 | 1.72 | Musculoskeletal | Stromal / connective | 0 | 1 | 3 | 12 | |
| 939 | Mood symptoms | PSYCH000029 | 1.72 | Psychiatric | Neural / glial | 41 | 3 | 7 | 10 | |
| 940 | CD84/GP1BA ratio | PRORT000524 | 1.71 | Protein ratios | Vascular | 17 | 2 | 10 | 19 | |
| 941 | SLITRK2 levels | PROLV001889 | 1.71 | Protein levels | Lymphocyte | 15 | 3 | 11 | 28 | |
| 942 | CHAD levels | PROLV000423 | 1.71 | Protein levels | Myeloid | 27 | 3 | 9 | 11 | |
| 943 | Immune cell marker, CD4 T cell | HEMAT000022 | 1.71 | Hematologic | Myeloid | 0 | 0 | 0 | 0 | |
| 944 | CD46/NECTIN2 ratio | PRORT000456 | 1.70 | Protein ratios | Vascular | 26 | 3 | 7 | 16 | |
| 945 | Eye disorder | OPHTH000008 | 1.70 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 946 | OMD/SOST ratio | PRORT001614 | 1.70 | Protein ratios | Myeloid | 31 | 2 | 3 | 6 | |
| 947 | DAB2/FKBP1B ratio | PRORT000836 | 1.69 | Protein ratios | Muscle / cardiac | 0 | 4 | 12 | 37 | |
| 948 | Family history, hypertension | VASCU000022 | 1.69 | Vascular | Hematopoietic progenitor | 2 | 0 | 1 | 5 | |
| 949 | SELPLG levels | PROLV001806 | 1.69 | Protein levels | Myeloid | 68 | 2 | 11 | 35 | |
| 950 | ADGRG2/NRCAM ratio | PRORT000036 | 1.69 | Protein ratios | Epithelial | 20 | 3 | 10 | 12 | |
| 951 | FNDC1 levels | PROLV000820 | 1.69 | Protein levels | Hepatocyte | 14 | 3 | 13 | 22 | |
| 952 | SEPHS1 levels | PROLV001812 | 1.69 | Protein levels | Neural / glial | 0 | 2 | 6 | 8 | |
| 953 | Peritonitis | GASTR000041 | 1.69 | Gastrointestinal | Muscle / cardiac | — | 1 | 2 | 6 | |
| 954 | PTPRM levels | PROLV001678 | 1.68 | Protein levels | Vascular | 80 | 2 | 8 | 18 | |
| 955 | ANKRD54 levels | PROLV000101 | 1.67 | Protein levels | Vascular | 2 | 2 | 4 | 18 | |
| 956 | WFIKKN2 levels | PROLV002192 | 1.67 | Protein levels | Myeloid | 35 | 0 | 4 | 11 | |
| 957 | PDGFB/PPP1R12A ratio | PRORT001640 | 1.67 | Protein ratios | Myeloid | 12 | 2 | 11 | 17 | |
| 958 | CD59/SCARB2 ratio | PRORT000483 | 1.67 | Protein ratios | Myeloid | 16 | 4 | 10 | 20 | |
| 959 | HGF/TNFSF14 ratio | PRORT001286 | 1.67 | Protein ratios | Hepatocyte | 19 | 5 | 14 | 27 | |
| 960 | CD109 levels | PROLV000309 | 1.66 | Protein levels | Neural / glial | 31 | 4 | 14 | 36 | |
| 961 | LTA levels | PROLV001239 | 1.66 | Protein levels | Lymphocyte | 112 | 3 | 17 | 32 | |
| 962 | Sarcoidosis | IMMUN000080 | 1.66 | Immunologic | Lymphocyte | 82 | 3 | 15 | 37 | |
| 963 | CDKN2D/MANF ratio | PRORT000579 | 1.65 | Protein ratios | Platelet | 12 | 3 | 5 | 11 | |
| 964 | Body fat percentage | BCOMP000004 | 1.65 | Body composition | Neural / glial | 409 | 3 | 9 | 19 | |
| 965 | Fatty liver disease, nonalcoholic | HPBIL000031 | 1.65 | Hepatopancreatobiliary | Vascular | 19 | 1 | 7 | 16 | |
| 966 | Metabolon metabolite | METAB000076 | 1.65 | Metabolites | Hepatocyte | 164 | 1 | 2 | 11 | |
| 967 | Skin and subcutaneous tissue disorder | DERMA000004 | 1.65 | Dermatologic | Muscle / cardiac | 0 | 0 | 0 | 0 | |
| 968 | Iris and ciliary body disorder | OPHTH000005 | 1.65 | Ophthalmic | Hepatocyte | 43 | 0 | 3 | 8 | |
| 969 | Phenylalanine | METAB000027 | 1.65 | Metabolites | Hepatocyte | 104 | 1 | 4 | 10 | |
| 970 | THBD levels | PROLV002025 | 1.64 | Protein levels | Vascular | 104 | 1 | 4 | 11 | |
| 971 | CX3CL1/DSG2 ratio | PRORT000807 | 1.64 | Protein ratios | Vascular | 33 | 1 | 6 | 8 | |
| 972 | CLIP2/DAB2 ratio | PRORT000664 | 1.64 | Protein ratios | Hepatocyte | 13 | 4 | 9 | 10 | |
| 973 | COL5A1 levels | PROLV000491 | 1.62 | Protein levels | Myeloid | 47 | 1 | 6 | 11 | |
| 974 | MPI levels | PROLV001334 | 1.62 | Protein levels | Stromal / connective | 10 | 5 | 10 | 15 | |
| 975 | RAB6A levels | PROLV001700 | 1.62 | Protein levels | Hepatocyte | 83 | 2 | 7 | 20 | |
| 976 | CD70 levels | PROLV000353 | 1.62 | Protein levels | Muscle / cardiac | 6 | 3 | 11 | 20 | |
| 977 | DLL4 levels | PROLV000627 | 1.61 | Protein levels | Epithelial | 2 | 1 | 10 | 16 | |
| 978 | Retinal vascular disorder | OPHTH000044 | 1.61 | Ophthalmic | Vascular | 0 | 1 | 6 | 13 | |
| 979 | Haematocrit | HEMAT000006 | 1.61 | Hematologic | Hepatocyte | 2,782 | 1 | 7 | 9 | |
| 980 | Cardiomyopathy | CARDI000040 | 1.61 | Cardiac | Muscle / cardiac | 51 | 2 | 3 | 3 | |
| 981 | FABP2/RBP2 ratio | PRORT001099 | 1.61 | Protein ratios | Neural / glial | 2 | 4 | 14 | 20 | |
| 982 | OGFR levels | PROLV001464 | 1.60 | Protein levels | Myeloid | 15 | 1 | 3 | 9 | |
| 983 | ECG-predicted BMI discrepancy | BMORP000008 | 1.59 | Body morphology | Muscle / cardiac | 0 | 2 | 5 | 20 | |
| 984 | GBP6 levels | PROLV000863 | 1.59 | Protein levels | Hepatocyte | 11 | 2 | 9 | 14 | |
| 985 | STAB2 levels | PROLV001956 | 1.59 | Protein levels | Granulosa cell | 78 | 2 | 11 | 19 | |
| 986 | White matter volume | NIMAG000028 | 1.59 | Neuroimaging | Neural / glial | 26 | 3 | 7 | 19 | |
| 987 | Amino acid metabolism disorder | METBL000001 | 1.58 | Metabolic | Lymphocyte | 0 | 2 | 3 | 9 | |
| 988 | CREG1/NAAA ratio | PRORT000752 | 1.57 | Protein ratios | Granulosa cell | 9 | 3 | 11 | 23 | |
| 989 | Subcortical volume | NIMAG000026 | 1.56 | Neuroimaging | Neural / glial | 6 | 0 | 0 | 0 | |
| 990 | DDHD2 levels | PROLV000609 | 1.55 | Protein levels | Vascular | 9 | 4 | 10 | 15 | |
| 991 | ANXA3/EDAR ratio | PRORT000105 | 1.55 | Protein ratios | Myeloid | 22 | 1 | 3 | 6 | |
| 992 | IL3RA levels | PROLV001074 | 1.55 | Protein levels | Granulosa cell | 51 | 1 | 10 | 25 | |
| 993 | DIABLO/PRKAR1A ratio | PRORT000893 | 1.55 | Protein ratios | Myeloid | 12 | 3 | 12 | 18 | |
| 994 | HGF/MMP8 ratio | PRORT001282 | 1.54 | Protein ratios | Hepatocyte | 3 | 3 | 11 | 19 | |
| 995 | Venous disease | VASCU000064 | 1.53 | Vascular | Vascular | 101 | 2 | 6 | 15 | |
| 996 | PRKAR2A levels | PROLV001632 | 1.53 | Protein levels | Myeloid | 15 | 3 | 5 | 18 | |
| 997 | DPY30 levels | PROLV000650 | 1.53 | Protein levels | Myeloid | 1 | 3 | 8 | 13 | |
| 998 | CCN3/COL6A3 ratio | PRORT000372 | 1.53 | Protein ratios | Stromal / connective | 26 | 0 | 3 | 5 | |
| 999 | Thyroid stimulating hormone, TSH | ENDOC000017 | 1.53 | Endocrine | Epithelial | 326 | 1 | 10 | 7 | |
| 1000 | Rotator cuff disorder | MSKEL000066 | 1.52 | Musculoskeletal | Neural / glial | 0 | 4 | 7 | 8 |